JPS649316B2 - - Google Patents
Info
- Publication number
- JPS649316B2 JPS649316B2 JP60016685A JP1668585A JPS649316B2 JP S649316 B2 JPS649316 B2 JP S649316B2 JP 60016685 A JP60016685 A JP 60016685A JP 1668585 A JP1668585 A JP 1668585A JP S649316 B2 JPS649316 B2 JP S649316B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- formula
- compound
- borane
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 58
- 238000000034 method Methods 0.000 claims description 32
- 125000000217 alkyl group Chemical group 0.000 claims description 13
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 11
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 10
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 8
- 150000007522 mineralic acids Chemical class 0.000 claims description 4
- 150000007524 organic acids Chemical class 0.000 claims description 4
- 150000001728 carbonyl compounds Chemical class 0.000 claims 1
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 39
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 23
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
- 229910000085 borane Inorganic materials 0.000 description 20
- 239000000203 mixture Substances 0.000 description 19
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 13
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 11
- 150000003839 salts Chemical class 0.000 description 11
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- DTVODKGBEXBXFW-BHIFYINESA-N (-)-3-methoxy butorphanol Chemical compound C([C@@]12C3=CC(OC)=CC=C3C[C@@]3([C@@]1(CCCC2)O)[H])CN3CC1CCC1 DTVODKGBEXBXFW-BHIFYINESA-N 0.000 description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- 238000002844 melting Methods 0.000 description 9
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 8
- 230000008018 melting Effects 0.000 description 8
- KFSLWBXXFJQRDL-UHFFFAOYSA-N peroxyacetic acid Substances CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 8
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 8
- NENLYAQPNATJSU-UHFFFAOYSA-N 1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline Chemical class C1NCCC2CCCCC21 NENLYAQPNATJSU-UHFFFAOYSA-N 0.000 description 7
- -1 14-hydroxy-3-substituted morphinans Chemical class 0.000 description 7
- 150000002009 diols Chemical class 0.000 description 7
- 150000002118 epoxides Chemical class 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000011541 reaction mixture Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 6
- IFKLAQQSCNILHL-QHAWAJNXSA-N butorphanol Chemical compound N1([C@@H]2CC3=CC=C(C=C3[C@@]3([C@]2(CCCC3)O)CC1)O)CC1CCC1 IFKLAQQSCNILHL-QHAWAJNXSA-N 0.000 description 6
- 235000011007 phosphoric acid Nutrition 0.000 description 6
- 238000003822 preparative gas chromatography Methods 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 5
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 5
- 229910052796 boron Inorganic materials 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 239000000543 intermediate Substances 0.000 description 5
- 238000007363 ring formation reaction Methods 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 4
- 229910015900 BF3 Inorganic materials 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- 239000000908 ammonium hydroxide Substances 0.000 description 4
- INAXVFBXDYWQFN-XHSDSOJGSA-N morphinan Chemical group C1C2=CC=CC=C2[C@]23CCCC[C@H]3[C@@H]1NCC2 INAXVFBXDYWQFN-XHSDSOJGSA-N 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- YBYCJQQRZPXLHU-UHFFFAOYSA-N 1,2,3,4,5,6,7,8-octahydroisoquinoline Chemical compound C1CNCC2=C1CCCC2 YBYCJQQRZPXLHU-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001412 amines Chemical group 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- LQNHRNOPWKZUSN-UHFFFAOYSA-N cyclobutylmethanamine Chemical compound NCC1CCC1 LQNHRNOPWKZUSN-UHFFFAOYSA-N 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- DLUQGORFFANYBS-QHAWAJNXSA-N n-cyclopropylmethyl-3-methoxy-14-hydroxymorphinan Chemical compound C([C@@]12C3=CC(OC)=CC=C3C[C@@]3([C@@]1(CCCC2)O)[H])CN3CC1CC1 DLUQGORFFANYBS-QHAWAJNXSA-N 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- PAMIQIKDUOTOBW-UHFFFAOYSA-N 1-methylpiperidine Chemical compound CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 229940035676 analgesics Drugs 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- 239000011260 aqueous acid Substances 0.000 description 2
- MCQRPQCQMGVWIQ-UHFFFAOYSA-N boron;methylsulfanylmethane Chemical compound [B].CSC MCQRPQCQMGVWIQ-UHFFFAOYSA-N 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Natural products OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- JFWMYCVMQSLLOO-UHFFFAOYSA-N cyclobutanecarbonyl chloride Chemical compound ClC(=O)C1CCC1 JFWMYCVMQSLLOO-UHFFFAOYSA-N 0.000 description 2
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- CHNLPLHJUPMEOI-UHFFFAOYSA-N oxolane;trifluoroborane Chemical compound FB(F)F.C1CCOC1 CHNLPLHJUPMEOI-UHFFFAOYSA-N 0.000 description 2
- 150000004965 peroxy acids Chemical class 0.000 description 2
- 229920000137 polyphosphoric acid Polymers 0.000 description 2
- 229940005657 pyrophosphoric acid Drugs 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- BCSVSDXHHARNMV-SXWPHCFWSA-N (1S,9R,10S)-17-(cyclobutylmethyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4,10-diol hydrochloride Chemical compound Cl.C([C@@]12C3=CC(O)=CC=C3C[C@@]3([C@@]1(CCCC2)O)[H])CN3CC1CCC1 BCSVSDXHHARNMV-SXWPHCFWSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- LRGZZEOWQURWFK-UHFFFAOYSA-N 1,2,3,4,4a,5,6,7-octahydroisoquinoline Chemical compound C1NCCC2CCCC=C21 LRGZZEOWQURWFK-UHFFFAOYSA-N 0.000 description 1
- JYUXDXWXTPSAEL-UHFFFAOYSA-N 1,4-dioxane;oxolane Chemical compound C1CCOC1.C1COCCO1 JYUXDXWXTPSAEL-UHFFFAOYSA-N 0.000 description 1
- XYPISWUKQGWYGX-UHFFFAOYSA-N 2,2,2-trifluoroethaneperoxoic acid Chemical compound OOC(=O)C(F)(F)F XYPISWUKQGWYGX-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ILNSWVUXAPSPEH-USXIJHARSA-N 3-methoxy-morphinan Chemical compound C1CCC[C@H]2[C@H]3CC4=CC=C(OC)C=C4[C@]21CCN3 ILNSWVUXAPSPEH-USXIJHARSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- PXRKCOCTEMYUEG-UHFFFAOYSA-N 5-aminoisoindole-1,3-dione Chemical compound NC1=CC=C2C(=O)NC(=O)C2=C1 PXRKCOCTEMYUEG-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- GIDAADNVOBPJGX-UHFFFAOYSA-N B.C1(=CC=CC=C1)C Chemical compound B.C1(=CC=CC=C1)C GIDAADNVOBPJGX-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-NJFSPNSNSA-N Carbon-14 Chemical compound [14C] OKTJSMMVPCPJKN-NJFSPNSNSA-N 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- XADCESSVHJOZHK-UHFFFAOYSA-N Meperidine Chemical compound C=1C=CC=CC=1C1(C(=O)OCC)CCN(C)CC1 XADCESSVHJOZHK-UHFFFAOYSA-N 0.000 description 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000008896 Opium Substances 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- ZVQOOHYFBIDMTQ-UHFFFAOYSA-N [methyl(oxido){1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-lambda(6)-sulfanylidene]cyanamide Chemical compound N#CN=S(C)(=O)C(C)C1=CC=C(C(F)(F)F)N=C1 ZVQOOHYFBIDMTQ-UHFFFAOYSA-N 0.000 description 1
- 239000000370 acceptor Substances 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical group 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- UWTDFICHZKXYAC-UHFFFAOYSA-N boron;oxolane Chemical compound [B].C1CCOC1 UWTDFICHZKXYAC-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 229950005499 carbon tetrachloride Drugs 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- OOXMFCUTPBVMQD-UHFFFAOYSA-N cyclobutyl-[1-[(4-methoxyphenyl)methyl]-3,4,5,6,7,8-hexahydro-1h-isoquinolin-2-yl]methanone Chemical compound C1=CC(OC)=CC=C1CC1C(CCCC2)=C2CCN1C(=O)C1CCC1 OOXMFCUTPBVMQD-UHFFFAOYSA-N 0.000 description 1
- 125000004850 cyclobutylmethyl group Chemical group C1(CCC1)C* 0.000 description 1
- ZOOSILUVXHVRJE-UHFFFAOYSA-N cyclopropanecarbonyl chloride Chemical compound ClC(=O)C1CC1 ZOOSILUVXHVRJE-UHFFFAOYSA-N 0.000 description 1
- GURWWFKKPNDYKZ-UHFFFAOYSA-N cyclopropyl-[1-[(4-methoxyphenyl)methyl]-3,4,5,6,7,8-hexahydro-1h-isoquinolin-2-yl]methanone Chemical compound C1=CC(OC)=CC=C1CC1C(CCCC2)=C2CCN1C(=O)C1CC1 GURWWFKKPNDYKZ-UHFFFAOYSA-N 0.000 description 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000010520 demethylation reaction Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- DGAXIBVHZVLXHA-UHFFFAOYSA-L disodium;dichloromethane;carbonate Chemical compound [Na+].[Na+].ClCCl.[O-]C([O-])=O DGAXIBVHZVLXHA-UHFFFAOYSA-L 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- NIQQIJXGUZVEBB-UHFFFAOYSA-N methanol;propan-2-one Chemical compound OC.CC(C)=O NIQQIJXGUZVEBB-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000003810 morphinanes Chemical class 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 1
- 239000004081 narcotic agent Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229960001027 opium Drugs 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- WLJNZVDCPSBLRP-UHFFFAOYSA-N pamoic acid Chemical compound C1=CC=C2C(CC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C(C(O)=O)=CC2=C1 WLJNZVDCPSBLRP-UHFFFAOYSA-N 0.000 description 1
- 229960000482 pethidine Drugs 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- ISIJQEHRDSCQIU-UHFFFAOYSA-N tert-butyl 2,7-diazaspiro[4.5]decane-7-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCCC11CNCC1 ISIJQEHRDSCQIU-UHFFFAOYSA-N 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 239000012485 toluene extract Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 239000012808 vapor phase Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/18—Aralkyl radicals
- C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00Â -Â C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00Â -Â C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/28—Morphinans
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
æ¬çºæã¯åŒïŒ¬ïŒ
ïŒåŒäžR2ã¯æ°ŽçŽ åã¯äœçŽã¢ã«ãã«ãããŸã
ã¯ã·ã¯ãããã«ã¡ãã«åã¯ã·ã¯ããããã«ã¡ãã«
ãããããè¡šããïŒã§ç€ºãããâ眮æãããâ
14âããããã·âïŒâ眮æãããâã¢ã«ãã€ãã³
é¡ã®äžéäœãšããŠæçšãªæ°èŠååç©ã®è£œé æ³ã«é¢
ããã æ¬çºæã®æ¹æ³ã®ç®çãšããæ°èŠäžéäœååç©ã¯
次åŒã«ãã€ãŠè¡šããããã åŒïŒ ïŒåŒäžïŒžã¯ã«ã«ããã«ïŒïŒïŒ¯ïŒåã¯H2ãã
ã¯ã·ã¯ããããã«åã¯ã·ã¯ãããã«ãããã€R2
ã¯äœçŽã¢ã«ãã«ãããããè¡šããïŒã æ¬çºæã®ç¬¬ïŒã®æ¹æ³ã¯äžèšåŒäžã®ïŒžãã«ã«ãã
ã«ã§ããååç©ã®è£œé æ³ã§ããã ïŒåŒäžã®ïŒ²ããã³R2ã¯åèšå®çŸ©ã®ãšããã§ã
ãïŒããã€ååç©ãç¡æ©ãŸãã¯ææ©ã®åŒ·é žã§åŠç
ããŠç®çååç©ã補é ããããšãç¹åŸŽãšããã æ¬çºæã®ç¬¬ïŒã®æ¹æ³ã¯äžèšåŒäžã®ïŒžãH2ã§ã
ãååç©ã®è£œé æ³ã§ããã ïŒåŒäžã®ïŒ²ããã³R2ã¯åèšå®çŸ©ã®ãšããã§ã
ãïŒããã€ååç©ãç¡æ©ãŸãã¯ææ©ã®åŒ·é žã§åŠç
ããŠäžèšç®çååç©ã®åŒäžã®ïŒžãã«ã«ããã«ã§ã
ãååç©ã補é ãã次ãã§è©²ã«ã«ããã«åºãéå
ããŠç®çååç©ã補é ããããšãç¹åŸŽãšããã ã¹ãªã«ãæ±ããé幎åã¯æ¥åžžç掻ã®çŸå®ããé
é¿ããããšãã人éã«ããè¬å€ä¹±çšã¯çŸä»£ç€ŸäŒã«
ãããŠçã äžè¬åãã€ã€ãããåºãä¹±çšãããŠã
ãè¬å€ã®çš®é¡ã¯ã³ãã€ã³ãã¢ã«ãããã¡ããªãžã³
çã®æ§ãªéº»é è¬ã§ããã補è¬å·¥æ¥çããã³æ¿åºã«
ãã€ãŠæ°ããéâèœæººæ§é®çå€ããã³ïŒåã¯ïŒéº»
é æå¶å€ãçºèŠãéçºããããšããè©Šã¿ã¯äžèšè¬
ã®æéãšéã®è«å€§ãªæ¶è²»ãšãªãæ§ãªåŒ·ãèœæººæ§ã®
çºã§ããã åºçºç©è³ªãšããŠããžãã¢ã«ã«ãã€ãé¡ã«ããã
ç¶ãåžè²©ããã«äŸ¿å©ãªåŒïŒ¬ã§ç€ºãããããšãç¹åŸŽ
ãšããäžèšååç©é¡ã®åææ³ã®éçºã«æ¬çºæè ç
ã¯ãšãããã ã ãããŠãïŒâïŒã¡ããªãã·ãã³ãžã«ïŒâïŒïŒ
ïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒâãªã¯ã¿ãããã€ãœ
ãããªã³ã®æ§ãªå®¹æã«å ¥æåºæ¥ãïŒâïŒïœâã¢ã«
ã³ãã·ãã³ãžã«ïŒâïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒ
ïŒïŒïŒâãªã¯ã¿ãããã€ãœãããªã³ããåŒïŒ¬ãã
ã€ååç©é¡ãå®å šã«åæãã補æ³ãéçºããã æ¬çºæè çã«ãã€ãŠè£œé ãããååç©é¡ã¯å¡©åº
æ§ã¢ã«ãã€ãã³æ žããã¡ããã¯æ¬¡ã®å³åŒã«ãã€ãŠ
çªå·ãã€ããŠè¡šããããïŒ ã¢ã«ãã€ãã³æ žäžã«ã¯ïŒé察称ççŽ ïŒïŒå°ïŒã
ããããïŒãš13äœçœ®ã«çµåããã€ãããšã¿ãç³»ã
ã·ã¹âïŒïŒïŒïŒâ軞ïŒâ溶èã«å¯Ÿã幟äœåŠçã«
æçžãããããïŒãžã¢ã¹ãã¬ãªã¡ã«ïŒã©ã»ãïŒå
ã®ã¿ãå¯èœã§ããããããã€ãŠãã®ã©ã»ãäœã¯ïŒ¢
ãšïŒ£ç°ã®æ¥åã«ãããŠãå³ã¡ççŽ 14ã®é åã«ãã
ãŠã®ã¿éã€ãŠãããå€åãããã®ã¯ïŒïŒ13ïŒãšïŒ
ïŒ14ïŒçµåéã®ã·ã¹ãšãã©ã³ã¹é¢ä¿ã®ã¿ã§ãã
ïŒããŠãŒãšãŒã¯åžãã¢ã«ãããŒãã¬ã¹ãEd.ãžãšãŒ
ãžãã¹ããã³ã¹ãé®çå€ã137ããŒãžïŒ1965ïŒå
ç §ïŒãïŒïŒ13ïŒãšïŒïŒ14ïŒçµåãäºã«ã·ã¹ã§ããã°
ååç©é¡ã¯æ®éâã¢ã«ãã€ãã³ã¹âãšãããâã¢
ã«ãã€ãã³âã®å³ç€ºæ³ã¯dlã©ã»ãæ··åç©ããã³ã
ã®åé¢ããïœãšïœç°æ§äœãå å«ããæå³ã§ããã åŒïŒ¬ã«ãã€ãŠç¹åŸŽãšããâã¢ã«ãã€ãã³âåå
ç©é¡ã¯åïŒå åŠç°æ§äœãå³ã¡å·Šææ§ããã³å³ææ§
ç°æ§äœãšããŠååšããããã®å åŠç°æ§äœã¯æ¬¡ã®ãš
ããå³ç€ºåºæ¥ãïŒ
ã¯ã·ã¯ãããã«ã¡ãã«åã¯ã·ã¯ããããã«ã¡ãã«
ãããããè¡šããïŒã§ç€ºãããâ眮æãããâ
14âããããã·âïŒâ眮æãããâã¢ã«ãã€ãã³
é¡ã®äžéäœãšããŠæçšãªæ°èŠååç©ã®è£œé æ³ã«é¢
ããã æ¬çºæã®æ¹æ³ã®ç®çãšããæ°èŠäžéäœååç©ã¯
次åŒã«ãã€ãŠè¡šããããã åŒïŒ ïŒåŒäžïŒžã¯ã«ã«ããã«ïŒïŒïŒ¯ïŒåã¯H2ãã
ã¯ã·ã¯ããããã«åã¯ã·ã¯ãããã«ãããã€R2
ã¯äœçŽã¢ã«ãã«ãããããè¡šããïŒã æ¬çºæã®ç¬¬ïŒã®æ¹æ³ã¯äžèšåŒäžã®ïŒžãã«ã«ãã
ã«ã§ããååç©ã®è£œé æ³ã§ããã ïŒåŒäžã®ïŒ²ããã³R2ã¯åèšå®çŸ©ã®ãšããã§ã
ãïŒããã€ååç©ãç¡æ©ãŸãã¯ææ©ã®åŒ·é žã§åŠç
ããŠç®çååç©ã補é ããããšãç¹åŸŽãšããã æ¬çºæã®ç¬¬ïŒã®æ¹æ³ã¯äžèšåŒäžã®ïŒžãH2ã§ã
ãååç©ã®è£œé æ³ã§ããã ïŒåŒäžã®ïŒ²ããã³R2ã¯åèšå®çŸ©ã®ãšããã§ã
ãïŒããã€ååç©ãç¡æ©ãŸãã¯ææ©ã®åŒ·é žã§åŠç
ããŠäžèšç®çååç©ã®åŒäžã®ïŒžãã«ã«ããã«ã§ã
ãååç©ã補é ãã次ãã§è©²ã«ã«ããã«åºãéå
ããŠç®çååç©ã補é ããããšãç¹åŸŽãšããã ã¹ãªã«ãæ±ããé幎åã¯æ¥åžžç掻ã®çŸå®ããé
é¿ããããšãã人éã«ããè¬å€ä¹±çšã¯çŸä»£ç€ŸäŒã«
ãããŠçã äžè¬åãã€ã€ãããåºãä¹±çšãããŠã
ãè¬å€ã®çš®é¡ã¯ã³ãã€ã³ãã¢ã«ãããã¡ããªãžã³
çã®æ§ãªéº»é è¬ã§ããã補è¬å·¥æ¥çããã³æ¿åºã«
ãã€ãŠæ°ããéâèœæººæ§é®çå€ããã³ïŒåã¯ïŒéº»
é æå¶å€ãçºèŠãéçºããããšããè©Šã¿ã¯äžèšè¬
ã®æéãšéã®è«å€§ãªæ¶è²»ãšãªãæ§ãªåŒ·ãèœæººæ§ã®
çºã§ããã åºçºç©è³ªãšããŠããžãã¢ã«ã«ãã€ãé¡ã«ããã
ç¶ãåžè²©ããã«äŸ¿å©ãªåŒïŒ¬ã§ç€ºãããããšãç¹åŸŽ
ãšããäžèšååç©é¡ã®åææ³ã®éçºã«æ¬çºæè ç
ã¯ãšãããã ã ãããŠãïŒâïŒã¡ããªãã·ãã³ãžã«ïŒâïŒïŒ
ïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒâãªã¯ã¿ãããã€ãœ
ãããªã³ã®æ§ãªå®¹æã«å ¥æåºæ¥ãïŒâïŒïœâã¢ã«
ã³ãã·ãã³ãžã«ïŒâïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒ
ïŒïŒïŒâãªã¯ã¿ãããã€ãœãããªã³ããåŒïŒ¬ãã
ã€ååç©é¡ãå®å šã«åæãã補æ³ãéçºããã æ¬çºæè çã«ãã€ãŠè£œé ãããååç©é¡ã¯å¡©åº
æ§ã¢ã«ãã€ãã³æ žããã¡ããã¯æ¬¡ã®å³åŒã«ãã€ãŠ
çªå·ãã€ããŠè¡šããããïŒ ã¢ã«ãã€ãã³æ žäžã«ã¯ïŒé察称ççŽ ïŒïŒå°ïŒã
ããããïŒãš13äœçœ®ã«çµåããã€ãããšã¿ãç³»ã
ã·ã¹âïŒïŒïŒïŒâ軞ïŒâ溶èã«å¯Ÿã幟äœåŠçã«
æçžãããããïŒãžã¢ã¹ãã¬ãªã¡ã«ïŒã©ã»ãïŒå
ã®ã¿ãå¯èœã§ããããããã€ãŠãã®ã©ã»ãäœã¯ïŒ¢
ãšïŒ£ç°ã®æ¥åã«ãããŠãå³ã¡ççŽ 14ã®é åã«ãã
ãŠã®ã¿éã€ãŠãããå€åãããã®ã¯ïŒïŒ13ïŒãšïŒ
ïŒ14ïŒçµåéã®ã·ã¹ãšãã©ã³ã¹é¢ä¿ã®ã¿ã§ãã
ïŒããŠãŒãšãŒã¯åžãã¢ã«ãããŒãã¬ã¹ãEd.ãžãšãŒ
ãžãã¹ããã³ã¹ãé®çå€ã137ããŒãžïŒ1965ïŒå
ç §ïŒãïŒïŒ13ïŒãšïŒïŒ14ïŒçµåãäºã«ã·ã¹ã§ããã°
ååç©é¡ã¯æ®éâã¢ã«ãã€ãã³ã¹âãšãããâã¢
ã«ãã€ãã³âã®å³ç€ºæ³ã¯dlã©ã»ãæ··åç©ããã³ã
ã®åé¢ããïœãšïœç°æ§äœãå å«ããæå³ã§ããã åŒïŒ¬ã«ãã€ãŠç¹åŸŽãšããâã¢ã«ãã€ãã³âåå
ç©é¡ã¯åïŒå åŠç°æ§äœãå³ã¡å·Šææ§ããã³å³ææ§
ç°æ§äœãšããŠååšããããã®å åŠç°æ§äœã¯æ¬¡ã®ãš
ããå³ç€ºåºæ¥ãïŒ
ãåŒã
ãåŒã
å
åŠç°æ§äœã¯äŸãã°ïœâåã¯ïœâé
ç³é
žåã¯ïŒ€
âïŒïŒïŒâαâããã¢ã«ã³ãã¢âã¹ã«ããªã³é žã
䜿ã€ãŠåœ¢æããããžã¢ã¹ãã¬ãªã¡ã«å¡©ã®åå¥æ¶åº
æ³ã«ãã€ãŠåé¢åã¯åé¢åºæ¥ãã æ¬æ现æžã«ãããŠâäœçŽã¢ã«ãã«âãšã¯ççŽ å
åïŒä¹è³ïŒåããã€ã¢ã«ãã«åºãäŸãã°ã¡ãã«ã
ãšãã«ããããã«ãã€ãœãããã«ãïœâããã«ã
ã€ãœããã«ãsecâããã«çãšå®çŸ©ãããâ補è¬äž
蚱容ãããé žä»å å¡©âãšã¯æ¬çºæã®ååç©é¡ã®ç¡
æ©ããã³ææ©é žå¡©é¡ã§ã¢ãã³å®èœåºããã€å»è¬ã®
ç¡æ¯å¡©é¡ãçæããã«æ®é䜿çšãããã¹ãŠã®å¡©é¡
ãå å«ãããã®ãšå®çŸ©ãããäŸããããã°åŒïŒ¬ã
ãã€ååç©é¡ãå¡©é žãç¡«é žãç¡é žãçé žãäºç
é žãèåæ°ŽçŽ é žããã¬ã€ã³é žããããé žãã¢ã¹ã³
ã«ãã³é žããããé žåã¯é ç³é žããã¢ã€ã³é žãã©
ãŠãªã³é žãã¹ãã¢ãªã³é žããã«ããã³é žããªã¬ã€
ã³é žãããªã¹ãã³é žãã©ãŠãªã«ç¡«é žãããã¿ã¬ã³
ã¹ã«ããªã³é žããªãã«é žãåã¯ãªãã¬ã³é žçãšæ··
åããŠçæããå¡©é¡ãããã ã¢ã«ãã€ãã³ååç©LVïŒïŒ²ãã·ã¯ããããã«å
ã¯ã·ã¯ãããã«ã§ãããã€R2ãäœçŽã¢ã«ãã«ã§
ããïŒããã³LXïŒïŒ²ãã·ã¯ããããã«åã¯ã·ã¯ã
ããã«ã§ããïŒã¯ïŒâïŒå·¥çšããæãå®å šåææ³
ã§è£œé ãããããã®åææ³ã¯å¹çãããŸãå·¥æ¥ç
ã«äŸ¿å©ãšæããããå³åŒã¯ïŒ®âã·ã¯ãããã«ã¡
ãã«â14âããããã·âïŒâã¡ããã·ã¢ã«ãã€ã
ã³ïŒLVaïŒã䜿ãâã·ã¯ãããã«ã¡ãã«âïŒïŒ
14âãžããããã·ã¢ã«ãã€ãã³ïŒLXaïŒã®è£œæ³
ã瀺ãã äŸïŒã®æ¹æ³ã«ããïœããã³ïœã®æ§ãªååç©
ã®ïŒïŒ10âãšããªãã·ãåºãéããŠïŒ²ãã·ã¯ãã
ãã«åã¯ã·ã¯ããããã«ã§ãããã€R2ãäœçŽã¢
ã«ãã«ã§ãã次ã®å³åŒïŒããã³ãã®ïŒå åŠç°æ§
äœïŒã«ãã€ãŠç€ºããã圢æ ã§ååšãããïŒïŒ10â
ãžãªãŒã«ååç©é¡ãåŸãããã äžèšã®æ¹æ³ã«ããååç©ïœããã³ïœã®ïŒïŒ
10âãšããªãã·ãåºãéããŠåŸãå®è³ªçã«ãã¹ãŠ
ã®çæç©ã¯ååç©VaïŒããã³ãã®å¯Ÿå¿ããé¡åïŒ
ã®ãã©ã³ã¹â9βïŒ10αâãžãªãŒã«é¢ä¿ããã¡å ã
ã«çè·¡éã®æãŸãããªããžãªãŒã«ïœãå«ããšè
ããããã æ ã«æ¬çºæã¯åŒïŒ ïŒåŒäžïŒžã¯ã«ã«ããã«ïŒïŒïŒ¯ïŒåã¯æ°ŽçŽ ãã
ã¯ã·ã¯ããããã«åã¯ã·ã¯ãããã«ãããŸãR2
ã¯äœçŽã¢ã«ãã«ãåºæ¥ãã°ã¡ãã«ãããããè¡šã
ãïŒã§ç€ºãããæ°èŠã®äžéäœãæäŸããã æ¬çºæã®äžéäœãçµã奜ãŸããæ æ§ã¯ (a) åŒïŒ ïŒåŒäžïŒ²ã¯ã·ã¯ãããã«åã¯ã·ã¯ããããã«
ãããŸãR2ã¯äœçŽã¢ã«ãã«ãè¡šããïŒããã€
ååç©ãäžæŽ»æ§ææ©æº¶åªäžã§ãã©ã³åã¯ãã©ã³
çºçæºã§éå ããŠåŒïŒ ïŒåŒäžïŒ²ãšR2ã¯äžã«å®çŸ©ãããšãããšããïŒ
ããã€ååç©ã®ç¡ŒçŽ é¯å¡©ãçæãã (b) ååç©ã®ç¡ŒçŽ é¯å¡©ãé žåŠçããŠåŒLVïŒ ïŒåŒäžïŒ²ãšR2ã¯äžã«å®çŸ©ãããšãããšããïŒ
ããã€ååç©ãçæãããã€å¿ èŠãªãã° (c) ååç©LVã®R2OâãšãŒãã«å®èœåºã
NaSC2H5ãèåæ°ŽçŽ é žãïŒèåç¡ŒçŽ åã¯ããª
ãžã³å¡©é žå¡©ãšåŠçããŠè£éããåŒLXïŒ ïŒåŒäžïŒ²ã¯äžã«å®çŸ©ãããšãããšããïŒã§ç€º
ãããååç©ãçæãã é£ç¶å·¥çšããæãåŒïŒ¬ïŒ ïŒåŒäžïŒ²ã¯ã·ã¯ãããã«åã¯ã·ã¯ããããã«
ãããŸãR2ã¯æ°ŽçŽ åã¯äœçŽã¢ã«ãã«ãããã
ãè¡šããïŒã§ç€ºãããååç©ã®è£œæ³ã§ããã åŒïŒ¬ãç¹åŸŽãšããååç©é¡ã®äžèšè£œæ³ã®å¥œãŸã
ãæ æ§ã¯æ¬¡ã®æ¹æ³ã§ããïŒ (1) å·¥çš(a)ã¯ããã©ããããã©ã³ããã«ãšã³åã¯
ãã³ãŒã³äžã§è¡ãªãïŒ (2) å·¥çš(a)ã«ãããŠåŒïŒ¶ååç©ã¯ãã©ã³ãžã¡ãã«
ç¡«åç©ã§éå ããïŒ (3) å·¥çš(a)ã«ãããŠïŒãµã€åç¡ŒçŽ ãïŒãµã€åç¡ŒçŽ
ããã©ããããã©ã³é¯ååç©åã¯ïŒãµã€åç¡ŒçŽ ã¢ã«ãã«ãšãŒãã¬ãŒãããæã矀ããéžã°ã
ãååç©ãšç¡Œæ°ŽçŽ åãããªãŠã ãåå¿ãããŠã
ã®å Žã§çºçãããã©ã³ã§åŒïŒ¶ããã€ååç©ãé
å ããïŒ (4) å·¥çš(a)ã«ãããŠååç©çŽïŒã¢ã«ã«å¯Ÿããã©
ã³1.33ä¹è³2.0ã¢ã«ã®å²åã§ãã©ã³ã䜿çšã
ãïŒ (5) å·¥çš(a)ã«ãããŠååç©çŽïŒã¢ã«ã«å¯Ÿããã©
ã³1.6ä¹è³1.9ã¢ã«ã®å²åã§ãã©ã³ã䜿çšããïŒ (6) å·¥çš(a)ã«ãããŠååç©çŽïŒã¢ã«ã«å¯Ÿããã©
ã³1.75ã¢ã«ã®å²åã§ãã©ã³ã䜿çšããïŒ (7) å·¥çš(a)ãçŽ50ä¹è³115âã®æž©åºŠã«å ç±ããŠè¡
ãªãïŒ (8) å·¥çš(a)ãéæµãã«ãšã³äžã§è¡ãªãïŒ (9) å·¥çš(b)ã«ãããŠååç©ã®ç¡ŒçŽ é¯å¡©ãçé žã
ãªã«ãçé žãããçé žããã³ããªçé žããæã
矀ããéžã°ããé žã§åŠçããïŒ (10) å·¥çš(b)ã«ãããŠååç©ã®ç¡ŒçŽ é¯å¡©ãç¡æ°Žç
é žããã³ïŒé žåçã§åŠçããïŒ (11) å·¥çš(b)ã«ãããŠååç©ã®ç¡ŒçŽ é¯å¡©ãå åé
å°ã®ç¡æ°Žçé žãšïŒé žåçã§åŠçããïŒ (12) å·¥çš(b)ã50â100âã®æž©åºŠç¯å²å ã§è¡ãªãïŒ (13) å·¥çš(b)ã70â75âã®æž©åºŠç¯å²å ã§è¡ãªãïŒ (14) å·¥çš(b)ã70â75âã®æž©åºŠç¯å²å ã§ç¡æ°Žçé ž
ããã³ïŒé žåçã䜿ã€ãŠè¡ãªãã ä»ã®å¥œãŸããæ æ§ã¯ (a) åŒïŒ ïŒåŒäžïŒ²ã¯ã·ã¯ãããã«åã¯ã·ã¯ããããã«
ãããŸãR2ã¯äœçŽã¢ã«ãã«ãããããè¡šããïŒ
ã§ç€ºãããååç©ãäžæŽ»æ§ææ©æº¶åªäžãã©ã³å
ã¯ãã©ã³çºçæºã§éå ããŠåŒïŒ ïŒåŒäžïŒ²ãšR2ã¯äžã«å®çŸ©ãããšãããšããïŒ
ããã€ååç©ã®ç¡ŒçŽ é¯å¡©ãçæãïŒ (b) ååç©ã®ç¡ŒçŽ é¯å¡©ãæ°Žæ§é žã§å æ°Žå解ããŠ
ååç©ãçæãïŒ (c) ååç©ãçé žããªã«ãçé žãããçé žãã
ã³ããªçé žããæã矀ããéžã°ããé žã§ç°åã
æ¬è³ªçã«å®äºããè¿åŠçããŠåŒLVïŒ ïŒåŒäžïŒ²ãšR2ã¯äžã«å®çŸ©ãããšãããšããïŒ
ã§ç€ºãããååç©ãçæãããã€å¿ èŠãªãã° (d) ååç©LVã®R2OâãšãŒãã«å®èœåºã
NaSC2H5ãèåæ°ŽçŽ é žãïŒèåç¡ŒçŽ åã¯ããª
ãžã³å¡©é žå¡©ã§è£éããŠåŒLXïŒ ïŒåŒäžïŒ²ã¯äžã«å®çŸ©ãããšãããšããïŒã§ç€º
ãããååç©ãçæããïŒ é£ç¶å·¥çšããæãåŒïŒ¬ïŒ ïŒåŒäžïŒ²ã¯ã·ã¯ãããã«åã¯ã·ã¯ããããã«
ãããŸãR2ã¯æ°ŽçŽ åã¯äœçŽã¢ã«ãã«ãããã
ãè¡šããïŒã§ç€ºãããååç©é¡ã®è£œæ³ã§ããã ãŸãå·¥çš(c)ã¯ååç©ããã©ã³ã§åŠçããåŸ
äžèšã®ãšããé žè§Šåªã§åŠçããåé¢å·¥çšã§è¡ãª
ãããšãåºæ¥ãã åŒïŒ¬ãç¹åŸŽãšããååç©é¡ã®äžèšè£œæ³ã®å¥œãŸã
ãæ æ§ã¯ (1) å·¥çš(c)ã70â90âã®æž©åºŠç¯å²ã§è¡ãªãïŒãã
ã³ (2) å·¥çš(c)ã80â85âã®æž©åºŠç¯å²ã§ç¡æ°Žçé žã䜿
çšããŠè¡ãªãïŒ ããšã§ããã æã奜ãŸããå®æœæ æ§ã¯ (a) åŒVaïŒ ããã€ååç©Vaããã«ãšã³äžã§ååç©VaçŽïŒ
ã¢ã«åœãçŽ1.75ã¢ã«ã®å²åã®ãã©ã³ãšçŽ50ä¹è³
115âã«å ç±ããŠéå ãåŒïœïŒ ããã€ååç©ã®ç¡ŒçŽ é¯å¡©ãçæãïŒ (b) ååç©ïœã®ç¡ŒçŽ é¯å¡©ãå åéå°ã®ç¡æ°Žç
é žïŒïŒé žåç6.4ïŒïŒã®æ··åç©ãšç°åãæ¬è³ªç
ã«å®äºããè¿çŽ70â75âã®æž©åºŠã«å ç±åŠçããŠ
åŒLVaïŒ ããã€ååç©ãçæãïŒãã€å¿ èŠãªãã° (c) ååç©LVaãNaSC2H5ãèåæ°ŽçŽ é žãïŒè
åç¡ŒçŽ åã¯ããªãžã³å¡©é žå¡©ã§è±ã¡ãã«ååå¿ã
è¡ãªã€ãŠåŒLXaïŒ ããã€ååç©ãçæãïŒãŸãå¿ èŠãªãã° (d) ååç©LXaããã®æè¡åéã§ç¥ãããæ¹æ³
ã§ãã®è£œè¬äžèš±å®¹ãããé žä»å å¡©ã«è»¢åããé£
ç¶å·¥çšããæãåŒLâ²ïŒ ïŒåŒäžïŒ²ã¯æ°ŽçŽ åã¯ã¡ãã«ãè¡šããïŒã§ç€ºã
ããååç©ã®è£œæ³ã§ããã ååç©é¡ïŒ®âã·ã¯ããããã«ã¡ãã«â14βâã
ãããªãã·âïŒâã¡ããªãã·âã¢ã«ãã€ãã³ã
âã·ã¯ãããã«ã¡ãã«â14βâããããªãã·âïŒ
âã¡ããªãã·ã¢ã«ãã€ãã³ãâã·ã¯ããããã«
ã¡ãã«âïŒïŒ14βâãžããããªãã·ã¢ã«ãã€ãã³
ããã³ïŒ®âã·ã¯ãããã«ã¡ãã«âïŒïŒ14βâãžã
ãããªãã·ã¢ã«ãã€ãã³ã¯ç¥ãããŠå± ãç±³åœç¹èš±
第3819635å·ã«èšèŒãããŠããã æ¬æ现æžã«ãããŠâäžæŽ»æ§ææ©æº¶åªâãšã¯åå¿
ã«ãã€ãŠå€åããªãæ§ã«åå¿ã«äŸããªãææ©æº¶åª
ãæå³ããããã®æ§ãªæº¶åªã¯å¡©åã¡ãã¬ã³ãã¯ã
ãããªã«ã ããžã¯ãããšã¿ã³ãããã©ã¯ããã¡ã¿
ã³ããã³ãŒã³ããã«ãšã³ããšãŒãã«ãé ¢é žãšã
ã«ããã·ã¬ã³ãããã©ããããã©ã³ãžãªã¯ãµã³ã
ãžã¡ãã«ã¢ã»ãã¢ããçã§ããã æ¬æ现æžäžæž©åºŠã¯ãã¹ãŠææ°ã床ã以ã€ãŠè¡šã
ããVPCã¯èžæ°çžã¯ãããã°ã©ãæ³ãæå³ããã
IRã¯èµ€å€ç·ã¹ãã¯ãã«ãããŸãNMRã¯æ žç£æ°å ±
鳎ã¹ãã¯ãã«ãããããæå³ããã 以äžã«æ¬çºæäžéäœã®è£œé ãçµãŠæçµçšéåå
ç©ã«è³ã補é å®éšäŸã瀺ãã äŸ ïŒ ïŒâã·ã¯ãããã«ã«ã«ããã«âïŒâïŒïœâã¡ã
ãªãã·ãã³ãžã«ïŒâïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒ
ïŒïŒïŒâãªã¯ã¿ãããã€ãœãããªã³ïŒïœïŒ å¡©åã¡ãã¬ã³200mläžã«ïŒâïŒïœâã¡ããªãã·
ãã³ãžã«ïŒâïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒâ
ãªã¯ã¿ãããã€ãœãããªã³å¡©é žå¡©ïœïŒ29.4ïœã
0.1ã¢ã«ïŒã溶解ã氷济äžã§å·åŽæ¹æããªããã
ããã«ããªãšãã«ã¢ãã³ïŒ22.2ïœã0.22ã¢ã«ïŒã
å ããããã®æ··åç©ãïŒä¹è³ïŒâã®æž©åºŠã«ä¿ã¡æ¹
æããªããããã«å¡©åã¡ãã¬ã³30mläžã«å¡©åã·ã¯
ãããã«ã«ã«ããã«ïŒ13ïœã0.107ã¢ã«ïŒãå«ã
液ãäžæ»Žã¥ã€å ãããåå¿æ··åç©ã宀枩ã§ïŒæé
æ¹æããåŸæ°Ž100mlãå ãæŽã«10ïŒ ç¡«é ž50mlãå
ããŠé žæ§ãšãå¡©åã¡ãã¬ã³å±€ãåé¢ãããæããª
ãã°ïœãå«ãå¡©åã¡ãã¬ã³æ¶²ãçŽæ¥æ¬¡å·¥çšã«äœ¿
çšããŠãããããããã¯æ¿çž®ããŠæ²¹ãšãæŸçœ®ãã
ã°åºåãããåºäœè©Šæãã¢ã»ãã³ããæ¶åºãããŠ
çµæ¶æ§çæç©ïœãåŸããããèç¹89â61âã äžã®æ¹æ³ã«ãããŠã¢ã·ã«ååå¿ã«ãããã³å容
äœãšããŠæ®é䜿ãããçš®ã ã®ææ©ç¬¬ïŒçŽã¢ãã³é¡
ã¯ããªãšãã«ã¢ãã³ã®ä»£ãã«äœ¿çšåºæ¥ãããã®æ§
ãªã¢ãã³é¡ã«ã¯ããªïŒäœçŽïŒã¢ã«ãã«ã¢ãã³é¡ã
äŸãã°ããªã¡ãã«ã¢ãã³ãããªãšãã«ã¢ãã³çã
ããªãžã³ããžã¡ãã«ã¢ããªã³ãâã¡ãã«ãããª
ãžã³çãããã äŸ ïŒ ïŒâã·ã¯ãããã«ã«ã«ããã«âïŒïŒ10âãšãã
ã·âïŒâïŒïœâã¡ããªãã·ãã³ãžã«ïŒãã«ãã
ãã€ãœãããªã³é¡ïŒïœãšïœïŒ æ³âéé ¢é žé žåæ³ å¡©åã¡ãã¬ã³230mläžã«ïŒâã·ã¯ãããã«ã«ã«
ããã«âïŒâïŒïœâã¡ããªãã·ãã³ãžã«ïŒâïŒïŒ
ïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒâãªã¯ã¿ãããã€ãœ
ãããªã³ïœïŒ0.1ã¢ã«ïŒã®æº¶æ¶²ã«éé ¢é žïŒ40ïŒ ã
23.8ïœã0.12ã¢ã«ïŒã枩床30â35âãä¿ã€æ§ãªé
床ã§å ãããåºæ¥ã液ã宀枩ã§ïŒæéæ¹æãæ°Ž
200mlãå ããåŸ10ïŒ éäºç¡«é žãããªãŠã 液100ml
ãå ããŠéå°ã®éé ¢é žãå解ãããå¡©åã¡ãã¬ã³
çžãåé¢ãæžå§æ¿çž®ããŠæ²¹ç¶æ®æž£ãåŸããããã
èžæ°çžã¯ãããã°ã©ãæ³åæïŒVPCïŒã«ãã€ãŠ
ããã¹ãåŠãã©ã³ã¹ïœãšã·ã¹ïœç°æ§äœãšããª
ãã·ãã®23ïŒ78ã®å²åã®æ··åç©ããæããã®ã§ã
ã€ããå¿ èŠãªãã°ãã®ãšããªãã·ãïŒçš®ãã¢ã«ã
ãåã¯ã·ãªã«ã«ã©ã ã䜿ã€ãŠã«ã©ã ã¯ãããã°ã©
ãæ³ã«ãã€ãŠåé¢åºæ¥ããïŒæº¶é¢å€ãžãšãã«ãšãŒ
ãã«äœ¿çšïŒã ïœâã¡ããªãã·ãã³ãžã«åºãšãªãã·ã©ã³åºã®ç«
äœé¢ä¿ã«ãããŠå°éãšããªãã·ãïŒïœãèç¹
118ãïŒã¯âãã©ã³ã¹åœ¢æ âããã¡ããŸãäž»ãšããª
ãã·ãïŒïœãèç¹82â84ãïŒã¯âã·ã¹åœ¢æ âã
ãã€ãŠããã æ³âãã«ããªãã«ãªãé ¢é žé žåæ³ å¡©åã¡ãã¬ã³125mläžã«ïŒâã·ã¯ãããã«ã«ã«
ããã«âïŒâïŒïœâã¡ããªãã·ãã³ãžã«ïŒâïŒïŒ
ïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒâãªã¯ã¿ãããã€ãœ
ãããªã³ïœïŒ0.05ã¢ã«ïŒã®æº¶æ¶²ã«çé žãããªãŠ
ã ïŒ20ïœã0.19ã¢ã«ïŒãå ãæ··åç©ã0ãã«å·åŽã
ããå¡©åã¡ãã¬ã³35mläžã«ç¡æ°Žããªãã«ãªãé ¢é ž
ïŒ16.6ïœã0.077ã¢ã«ïŒãš90ïŒ éé žåæ°ŽçŽ ïŒ2.94ïœã
0.077ã¢ã«ïŒãïŒâã§æ··åããŠãã«ããªãã«ãªã
é ¢é žã®æ¶²ãã€ãã€ããïœã®åå¿æ··åç©ã«éé žæ¶²
ãåå¿æž©åºŠãïŒä¹è³5ãã«ä¿ã€æ§ãªé床ã§æ»Žå ã
ããæ·»å çµäºåŸåå¿æ··åç©ãïŒä¹è³ïŒâã§30åé
æ¹æããåŸ10ïŒ éäºç¡«é žãããªãŠã 液ãå ããŠ
CO2ã®çºçãæ¢ãè¿æ¹æããŠéå°ã®éé žãå解ã
ããå¡©åã¡ãã¬ã³çžãæ°ŽæŽãç¡æ°Žç¡«é žãããªãŠã
äžããšãããŠä¹Ÿç¥ãæžå§æ¿çž®ããŠæ²¹ç¶æ®æž£ãåŸ
ããããã¯VPCã«ããã°ãã©ã³ã¹ïŒã·ã¹æ¯35ïŒ
65ã®ïœãšïœç°æ§äœãšããªãã·ãã§ãã€ãã äŸ ïŒ ïŒâã·ã¯ãããã«ã«ã«ããã«âïŒïŒ10âãžãã
ããªãã·âïŒâïŒïœâã¡ããªãã·ãã³ãžã«ïŒã
ã«ãããã€ãœãããªã³ïŒVaãšïœïŒ äŸïŒã®éé ¢é žé žåæ³ããã®ïœãšïœç°æ§äœãš
ããªãã·ãæ··åç©ãã¢ã»ãã³30mlã«æº¶è§£ãïŒâã«
å·åŽããããã®æ¶²ã«å ã¥æ°Ž30mlãå ããåŸæž©åºŠã
25â以äžã«ä¿ã€æ§ãªé床ã§æ¿ç¡«é ž30mlãå ããã
åå¿æ··åç©ã25ãã§1.5æéæ¹æããåŸæ°Ž150mlãš
ãã«ãšã³300mlãå ããããã®ïŒçžæ··åç©ãæ°Žé ž
åãããªãŠã 溶液ã§ã¢ã«ã«ãªæ§ãšããã«ãšã³å±€ã
åé¢ãæ¿çž®ããŠæ²¹ç¶æ®æž£ãåŸãããã®æ²¹ãã·ã¯ã
ãããµã³300mlãšæ¹æãåŸãçœè²åºäœæžæ¿æ¶²ã
éããŠåºäœãæéããããã®çœè²åºäœã¯VPCã«
ãã€ãŠäž»ãšããŠæããã©ã³ã¹ãžãªãŒã«Vaãšå°é
ã®ãã©ã³ã¹ç°æ§äœãžãªãŒã«ïœããæããšããã€
ããæåã®ã¢ãã³ïœããèšç®ããVaåçã¯75
ïŒ ã§ãã€ããã·ã¯ããããµã³æ¶²ã¯ç¡«é žã§åŠçã
ãŠæŽã«ãã©ã³ã¹ãžãªãŒã«ã®10ïŒ åçãåŸããçœè²
åºäœãã¢ã»ããããªã«ããæŽã«æ¶åºç²Ÿè£œããŠèç¹
145â147ãã®ç©è³ªãåŸããäžèšäœ¿çšã®æ¿ç¡«é žã®ä»£
ãã«ç¡é žãå¡©é žãèåæ°ŽçŽ é žã®æ§ãªä»ã®é žé¡åã¯
ã¢ã«ãã«ã¹ã«ããªã³é žãããªãã«ãªãé ¢é žã®æ§ãª
匷ææ©é žé¡ã䜿çšåºæ¥ãã äžèšæ¹æ³ã«ããå°éã®çŽãã©ã³ã¹ãšããªãã·ã
ïœã®å æ°Žå解ã¯æããã©ã³ã¹ãžãªãŒã«Vaã®ã¿
ãåŸããããäž»ã·ã¹ãšããªãã·ãïœã®å æ°Žå解
ã¯æããã©ã³ã¹ãžãªãŒã«Vaãšå ±ã«å°éã®ãã©ã³
ã¹ãžãªãŒã«ç°æ§äœïœãåºæ¥ãããã®VaïŒïœ
æ¯çã¯86ïŒ14ã§ããã äŸ ïŒ ïŒâã·ã¯ãããã«ã¡ãã«âïŒïŒ10âãžããããª
ãã·âïŒâïŒïœâã¡ããªãã·ãã³ãžã«ïŒãã«ã
ããã€ãœãããªã³ïŒïœïŒ ããã©ããããã©ã³300mläžã«ïŒâã·ã¯ããã
ã«ã«ã«ããã«âïŒïŒ10âãžããããªãã·âïŒâ
ïŒïœâã¡ããªãã·ãã³ãžã«ïŒãã«ãããã€ãœãã
ãªã³ïŒ30.0ïœã0.08ã¢ã«ïŒã®æº¶æ¶²ã«çªçŽ é°å²æ°ã®
ããšã§æ³šå°éããšãããŠãã©ã³ãžã¡ãã«ç¡«åç©ç
ïŒãïŒæº¶æ¶²ïŒ14mlã0.14ã¢ã«ïŒãå ãããåŸãæ··
åç©ãïŒæééæµå ç±ããåŸæžå§æ¿çž®ã溶åªãé€
å»ãããåŸãã·ã¯ãããã«ã¡ãã«ã¢ãã³ïœã®ã
ã©ã³é¯ååç©ã¯çŽæ¥æ¬¡åå¿ã«äœ¿çšåºæ¥ããåã¯å¡©
é žã®æ§ãªæ°Žæ§é žã§å æ°Žå解ããŠïœïŒèç¹120â
122âïŒãåŸãããããã©ã³ã¹ãžãªãŒã«Vaã¢ãã
å®èœåºã次ã®ãã©ã³çºçæºã§éå ããŠãïœãåŸ
ãããïŒ ïŒ ãã©ã³âããã©ããããã©ã³é¯ååç©ã ïŒ ç¡Œæ°ŽçŽ åãããªãŠã ãšïŒãµã€åç¡ŒçŽ ã¬ã¹åã¯
ïŒãµã€åç¡ŒçŽ ããã©ããããã©ã³é¯ååç©åã¯
ïŒãµã€åç¡ŒçŽ ã¢ã«ãã«ãšãŒãã¬ãŒãã䜿çšããŠ
ããã©ããããã©ã³äžãã®å Žã§çºçãããã©
ã³ã äŸ ïŒ ïŒ®âã·ã¯ãããã«ã¡ãã«â14βâããããªãã·
âïŒâã¡ããªãã·ã¢ã«ãã€ãã³ïŒLVaïŒ ïŒ¡æ³âŠãã©ã³é¯ååç©ã䜿çšããç°ååå¿ äŸïŒã®ãã©ã³éå åå¿ããåŸããã©ã³é¯ååç©
æ®æž£ã«ç¡æ°Žçé žïŒ85ïŒ çé žãšïŒé žåçããã€ãã€
ãïŒ320ïœãšïŒé žåç50ïœãå ããããã®æ··åç©
ã宀枩ã§30åéæ¹æããåŸ70â75âã§ïŒæéæ¹æ
ãããåå¿æ··åç©ãæ°Ž200mlã§ããããåŸæ¿æ°Žé ž
åã¢ã³ã¢ããŠã 600mlãšç æ°·ïŒã®æ··åç©äžã«æ³š
å ¥ããããã®æ··åç©ãããã¿ã³400mlã§æœåºãã
ãã¿ã³æœåºæ¶²ãç¡«é žãããªãŠã äžããšãããŠä¹Ÿç¥
ããåŸæ¿çž®ããŠæ²¹ç¶çæç©LVa23.1ïœïŒ85ïŒ å
çïŒãåŸãããã®æ²¹ãã¢ã»ãã³ã«ãšããç¡æ°Žå¡©å
æ°ŽçŽ ã¬ã¹ã§åŠçããŠçæç©LVaã®çµæ¶æ§å¡©é žå¡©
ãåŸããèç¹248â250âã æ³âŠã©ããªç¡ŒçŽ é¯å¡©ã䜿çšãã¬ç°åæ¹æ³ ïŒâã·ã¯ãããã«ã¡ãã«âïŒïŒ10âãžããããª
ãã·âïŒâïŒïœâã¡ããªãã·ãã³ãžã«ïŒãã«ãã
ãã€ãœãããªã³a1.5ïœãšç¡æ°Žçé ž16.0ïœã80â
85ãã§23æéæ¹æããããã®åå¿æ··åç©ãæ°Ž20ml
ã§ããããåŸæ°·ãšæ¿æ°Žé žåã¢ã³ã¢ããŠã 35mlã®æ··
åç©äžã«æ³šå ¥ãããæ··åç©ãå¡©åã¡ãã¬ã³40mlã§
æœåºãæœåºæ¶²ãæ¿çž®ããŠæ²¹1.15ïœãåŸããèžæ°çž
ã¯ãããã°ã©ãæ³âåå åææ³ã«ãã€ãŠæ²¹ã¯æã
âã·ã¯ãããã«ã¡ãã«â14βâããããªãã·â
ïŒâã¡ããªãã·ã¢ã«ãã€ãã³LVa57ïŒ ãè±æ°Žã
ããå¯æç©27ïŒ ããã³éç°åïœåæç©è³ª15ïŒ ã
ãæããã®ã§ãã€ãã äŸ ïŒ å·Šææ§ïŒ®âã·ã¯ãããã«ã¡ãã«â14βâããã
ãªãã·âïŒâã¡ããªãã·ã¢ã«ãã€ãã³ïŒLVaâ²ïŒ äŸïŒã®æ¹æ³ã«ãããŠå³ææ§ïŒâïŒïœâã¡ããªã
ã·ãã³ãžã«ïŒâïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒ
âãªã¯ã¿ãããã€ãœãããªã³å¡©é žå¡©ã®ä»£ãã«ã©ã»
ãäœïœãçšã次ãã§äŸïŒãïŒã®æ¹æ³ãé©çšããŠ
å·Šææ§çæç©LVaâ²ãåŸãã äŸïŒãšïŒã®æ¹æ³ã次ã®ãšããè¡ãªã€ãããã«ãš
ã³100mläžã«å·Šææ§ïŒâã·ã¯ãããã«ã«ã«ããã«
âïŒïŒ10âãžããããªãã·âïŒâïŒïœâã¡ããªã
ã·ãã³ãžã«ïŒãã«ãããã€ãœãããªã³ïŒ10ïœã
0.0267ã¢ã«ïŒã®æ¶²ã«çªçŽ é°å²æ°ã®ããšã§æ³šå°éã
ãšãããŠãã©ã³ãžã¡ãã«ç¡«åç©ç溶液ïŒïŒmlã
0.057ã¢ã«ïŒãå ãããåŸã液ãïŒæééæµèžç
ãæžå§æ¿çž®ããŠçŽ40mlã®æº¶åªãé€å»ãå·Šææ§ã·ã¯
ãããã«ã¡ãã«ã¢ãã³aâ²ã®ãã©ã³é¯ååç©ãçŽ
æ¥ç°ååå¿ã«äœ¿ã€ãã å·Šææ§ã·ã¯ãããã«ã¡ãã«ã¢ãã³aâ²ã®ç°åå
å¿ã¯ç¡æ°Žçé ž200ïœãšïŒé žåç35ïœãïŒâ25ãã®æž©
床ã§æ¹æããªããäžèšãã«ãšã³âãã©ã³é¯ååç©
æ··åç©ãå°ãã¥ã€å ããŠè¡ãªã€ããæ·»å å®äºåŸæ··
åç©ã70âã«å ç±ãïŒæéæ¹æããåŸãããæ¿æ°Ž
é žåã¢ã³ã¢ããŠã 400mlãšçŽ25ãã®æž©åºŠã«ä¿ã€ã«å
åã®æ°·ãšã®æ··åç©äžã«æ³šå ¥ããããã®æ··åç©ãã
ã«ãšã³ã§æœåºããã«ãšã³æœåºæ¶²ãæ°ŽæŽããåŸæžå§
æ¿çž®ããŠå·Šææ§ïŒ®âã·ã¯ãããã«ã¡ãã«â14βâ
ããããªãã·âïŒâã¡ããªãã·ã¢ã«ãã€ãã³
ïŒLVaâ²ïŒå¡©åºãåŸãããã®æ²¹ç¶å¡©åºãç¡«é žã§åŠç
ããŠç¡«é žå¡©ã«è»¢åãå·Šææ§ïŒ®âã·ã¯ãããã«ã¡ã
ã«â14βâããããªãã·âïŒâã¡ããªãã·âã¢ã«
ãã€ãã³7.2ïœãåŸããèç¹232â237âïŒå解ïŒ
ãαãdâ55.4âãïŒïœïŒ0.56ãCH3OHïŒã äŸ ïŒ ïŒâã·ã¯ããããã«ã«ã«ããã«âïŒâïŒïœâã¡
ããªãã·ãã³ãžã«ïŒâïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒ
ïŒïŒïŒïŒïŒâãªã¯ã¿ãããã€ãœãããªã³ïŒ
ïœïŒ äŸïŒã®æ¹æ³ã«ãããŠäœ¿çšããå¡©åã·ã¯ãããã«
ã«ã«ããã«ã®ä»£ãã«çã¢ã«éã®å¡©åã·ã¯ãããã
ã«ã«ã«ããã«ã䜿ã€ãŠéŠé¡ç©è³ªïœãçæããã äŸ ïŒ ïŒâã·ã¯ããããã«ã«ã«ããã«âïŒïŒ10âãšã
ãã·âïŒâïŒïœâã¡ããªãã·ãã³ãžã«ïŒãã«ã
ããã€ãœãããªã³é¡ïŒïœããã³ïœïŒ äŸïŒã®æ¹æ³ã«ãããŠäœ¿çšããã©ã»ãäœïœã®ä»£
ãã«çã¢ã«éã®ïœã䜿ã€ãŠéŠé¡ååç©ïœãš
ïœãçæããã äŸ ïŒ ïŒâã·ã¯ããããã«ã«ã«ããã«âïŒïŒ10âãžã
ãããªãã·âïŒâïŒïœâã¡ããªãã·ãã³ãžã«ïŒ
ãã«ãããã€ãœãããªã³ïŒïœïŒïœïŒ äŸïŒã®æ¹æ³ã«ãããŠäœ¿çšããã©ã»ãäœïœãã
ã³ïœã®ä»£ãã«çã¢ã«éã®ïœããã³ïœã䜿ã€
ãŠéŠé¡ååç©ïœãšïœãçæããã äŸ 10 ïŒâã·ã¯ããããã«ã¡ãã«âïŒïŒ10âãžããã
ãªãã·âïŒâïŒïœâã¡ããªãã·ãã³ãžã«ïŒãã«
ãããã€ãœãããªã³ïŒïœïŒ äŸïŒã®æ¹æ³ã«ãããŠäœ¿çšããã©ã»ãäœïœã®ä»£
ãã«çã¢ã«éã®Vbã䜿ã€ãŠéŠé¡ååç©ïœãç
æããã äŸ 11 âã·ã¯ããããã«ã¡ãã«â14βâããããªã
ã·âïŒâã¡ããªãã·ã¢ã«ãã€ãã³ïŒLVbïŒ äŸïŒã®æ¹æ³ã«ãããŠäœ¿çšããã©ã»ãäœïœã®ä»£
ãã«çã¢ã«éã®ïœã䜿ã€ãŠéŠé¡çæç©LVbã
çæããã äŸ 12 âã·ã¯ãããã«ã¡ãã«âïŒïŒ14âãžããããª
ãã·ã¢ã«ãã€ãã³ïŒLXaïŒ 48ïŒ HBr10mläžã«ïŒ®âã·ã¯ãããã«ã¡ãã«â
14βâããããªãã·âïŒâã¡ããªãã·ã¢ã«ãã€ã
ã³ïŒLVaïŒïŒ1.0ïœã2.58ããªã¢ã«ïŒã®æ··åç©ãçª
çŽ é°å²æ°ã®ããšã§ïŒåééæµèžçãããå·åŽåŸå
å¿æ··åç©ãæ°Žã§çšéãæ°Žé žåã¢ã³ã¢ããŠã 氎溶液
ã§ã¢ã«ã«ãªæ§ãšããããã®æ¶²ãã¯ããããªã«ã ã§
æ°åæœåºã䜵ããæœåºæ¶²ãç¡æ°Žç¡«é žãããªãŠã äž
ããšãããŠä¹Ÿç¥ããã溶åªãèžçºããŠåŸãæ²¹730
mgã也ç¥ãšãŒãã«ã«ãšããåŸã液ãããè»åâå
çããšããéããã液ãå¡©åæ°ŽçŽ ã飜åãã
ã也ç¥ãšãŒãã«ã§åŠçãåŸãå¡©é žå¡©ãæéããŠã¡
ã¿ããŒã«âã¢ã»ãã³ããæ¶åºãããŠïŒ®âã·ã¯ãã
ãã«ã¡ãã«âïŒïŒ14âãžããããªãã·ã¢ã«ãã€ã
ã³å¡©é žå¡©LXa565mgïŒ56.5ïŒ ïŒãåŸããèç¹272â
274ãïŒå解ïŒãIRãšNMRã¹ãã¯ãã«ã¯æ§é ãšäžèŽ
ããã C21H29NO2ã»HClã»ïŒïŒïŒCH3OHã«å¯Ÿããåæå€ ïŒ ïŒ èšç®å€ïŒïŒ£ã67.97ïŒïŒšã8.49ïŒïŒ®ã3.49ã 枬å®å€ïŒïŒ£ã68.10ïŒïŒšã8.14ïŒïŒ®ã3.80ã äžèšã®ä¹Ÿç¥ãšãŒãã«æ¶²ãé©åœããé žé¡ã§é žæ§
ãšããŠLXaã®çš®ã ã®â補è¬äžèš±å®¹ãããé žä»å
å¡©é¡âãåŸãã âã·ã¯ãããã«ã¡ãã«â14βâããããªãã·
âïŒâã¡ããªãã·ã¢ã«ãã€ãã³ã®ïŒâã¡ããªãã·
ãšãŒãã«å®èœåºã¯NaSC2H5ãïŒèåç¡ŒçŽ ãåã¯
ããªãžã³å¡©é žå¡©ã®æ§ãªãšãŒãã«è£éå€ã§åŠçããŠ
è£éãæããžã¡ãã«åããçæç©LXaãåŸãã
ãšãåºæ¥ãã
âïŒïŒïŒâαâããã¢ã«ã³ãã¢âã¹ã«ããªã³é žã
䜿ã€ãŠåœ¢æããããžã¢ã¹ãã¬ãªã¡ã«å¡©ã®åå¥æ¶åº
æ³ã«ãã€ãŠåé¢åã¯åé¢åºæ¥ãã æ¬æ现æžã«ãããŠâäœçŽã¢ã«ãã«âãšã¯ççŽ å
åïŒä¹è³ïŒåããã€ã¢ã«ãã«åºãäŸãã°ã¡ãã«ã
ãšãã«ããããã«ãã€ãœãããã«ãïœâããã«ã
ã€ãœããã«ãsecâããã«çãšå®çŸ©ãããâ補è¬äž
蚱容ãããé žä»å å¡©âãšã¯æ¬çºæã®ååç©é¡ã®ç¡
æ©ããã³ææ©é žå¡©é¡ã§ã¢ãã³å®èœåºããã€å»è¬ã®
ç¡æ¯å¡©é¡ãçæããã«æ®é䜿çšãããã¹ãŠã®å¡©é¡
ãå å«ãããã®ãšå®çŸ©ãããäŸããããã°åŒïŒ¬ã
ãã€ååç©é¡ãå¡©é žãç¡«é žãç¡é žãçé žãäºç
é žãèåæ°ŽçŽ é žããã¬ã€ã³é žããããé žãã¢ã¹ã³
ã«ãã³é žããããé žåã¯é ç³é žããã¢ã€ã³é žãã©
ãŠãªã³é žãã¹ãã¢ãªã³é žããã«ããã³é žããªã¬ã€
ã³é žãããªã¹ãã³é žãã©ãŠãªã«ç¡«é žãããã¿ã¬ã³
ã¹ã«ããªã³é žããªãã«é žãåã¯ãªãã¬ã³é žçãšæ··
åããŠçæããå¡©é¡ãããã ã¢ã«ãã€ãã³ååç©LVïŒïŒ²ãã·ã¯ããããã«å
ã¯ã·ã¯ãããã«ã§ãããã€R2ãäœçŽã¢ã«ãã«ã§
ããïŒããã³LXïŒïŒ²ãã·ã¯ããããã«åã¯ã·ã¯ã
ããã«ã§ããïŒã¯ïŒâïŒå·¥çšããæãå®å šåææ³
ã§è£œé ãããããã®åææ³ã¯å¹çãããŸãå·¥æ¥ç
ã«äŸ¿å©ãšæããããå³åŒã¯ïŒ®âã·ã¯ãããã«ã¡
ãã«â14âããããã·âïŒâã¡ããã·ã¢ã«ãã€ã
ã³ïŒLVaïŒã䜿ãâã·ã¯ãããã«ã¡ãã«âïŒïŒ
14âãžããããã·ã¢ã«ãã€ãã³ïŒLXaïŒã®è£œæ³
ã瀺ãã äŸïŒã®æ¹æ³ã«ããïœããã³ïœã®æ§ãªååç©
ã®ïŒïŒ10âãšããªãã·ãåºãéããŠïŒ²ãã·ã¯ãã
ãã«åã¯ã·ã¯ããããã«ã§ãããã€R2ãäœçŽã¢
ã«ãã«ã§ãã次ã®å³åŒïŒããã³ãã®ïŒå åŠç°æ§
äœïŒã«ãã€ãŠç€ºããã圢æ ã§ååšãããïŒïŒ10â
ãžãªãŒã«ååç©é¡ãåŸãããã äžèšã®æ¹æ³ã«ããååç©ïœããã³ïœã®ïŒïŒ
10âãšããªãã·ãåºãéããŠåŸãå®è³ªçã«ãã¹ãŠ
ã®çæç©ã¯ååç©VaïŒããã³ãã®å¯Ÿå¿ããé¡åïŒ
ã®ãã©ã³ã¹â9βïŒ10αâãžãªãŒã«é¢ä¿ããã¡å ã
ã«çè·¡éã®æãŸãããªããžãªãŒã«ïœãå«ããšè
ããããã æ ã«æ¬çºæã¯åŒïŒ ïŒåŒäžïŒžã¯ã«ã«ããã«ïŒïŒïŒ¯ïŒåã¯æ°ŽçŽ ãã
ã¯ã·ã¯ããããã«åã¯ã·ã¯ãããã«ãããŸãR2
ã¯äœçŽã¢ã«ãã«ãåºæ¥ãã°ã¡ãã«ãããããè¡šã
ãïŒã§ç€ºãããæ°èŠã®äžéäœãæäŸããã æ¬çºæã®äžéäœãçµã奜ãŸããæ æ§ã¯ (a) åŒïŒ ïŒåŒäžïŒ²ã¯ã·ã¯ãããã«åã¯ã·ã¯ããããã«
ãããŸãR2ã¯äœçŽã¢ã«ãã«ãè¡šããïŒããã€
ååç©ãäžæŽ»æ§ææ©æº¶åªäžã§ãã©ã³åã¯ãã©ã³
çºçæºã§éå ããŠåŒïŒ ïŒåŒäžïŒ²ãšR2ã¯äžã«å®çŸ©ãããšãããšããïŒ
ããã€ååç©ã®ç¡ŒçŽ é¯å¡©ãçæãã (b) ååç©ã®ç¡ŒçŽ é¯å¡©ãé žåŠçããŠåŒLVïŒ ïŒåŒäžïŒ²ãšR2ã¯äžã«å®çŸ©ãããšãããšããïŒ
ããã€ååç©ãçæãããã€å¿ èŠãªãã° (c) ååç©LVã®R2OâãšãŒãã«å®èœåºã
NaSC2H5ãèåæ°ŽçŽ é žãïŒèåç¡ŒçŽ åã¯ããª
ãžã³å¡©é žå¡©ãšåŠçããŠè£éããåŒLXïŒ ïŒåŒäžïŒ²ã¯äžã«å®çŸ©ãããšãããšããïŒã§ç€º
ãããååç©ãçæãã é£ç¶å·¥çšããæãåŒïŒ¬ïŒ ïŒåŒäžïŒ²ã¯ã·ã¯ãããã«åã¯ã·ã¯ããããã«
ãããŸãR2ã¯æ°ŽçŽ åã¯äœçŽã¢ã«ãã«ãããã
ãè¡šããïŒã§ç€ºãããååç©ã®è£œæ³ã§ããã åŒïŒ¬ãç¹åŸŽãšããååç©é¡ã®äžèšè£œæ³ã®å¥œãŸã
ãæ æ§ã¯æ¬¡ã®æ¹æ³ã§ããïŒ (1) å·¥çš(a)ã¯ããã©ããããã©ã³ããã«ãšã³åã¯
ãã³ãŒã³äžã§è¡ãªãïŒ (2) å·¥çš(a)ã«ãããŠåŒïŒ¶ååç©ã¯ãã©ã³ãžã¡ãã«
ç¡«åç©ã§éå ããïŒ (3) å·¥çš(a)ã«ãããŠïŒãµã€åç¡ŒçŽ ãïŒãµã€åç¡ŒçŽ
ããã©ããããã©ã³é¯ååç©åã¯ïŒãµã€åç¡ŒçŽ ã¢ã«ãã«ãšãŒãã¬ãŒãããæã矀ããéžã°ã
ãååç©ãšç¡Œæ°ŽçŽ åãããªãŠã ãåå¿ãããŠã
ã®å Žã§çºçãããã©ã³ã§åŒïŒ¶ããã€ååç©ãé
å ããïŒ (4) å·¥çš(a)ã«ãããŠååç©çŽïŒã¢ã«ã«å¯Ÿããã©
ã³1.33ä¹è³2.0ã¢ã«ã®å²åã§ãã©ã³ã䜿çšã
ãïŒ (5) å·¥çš(a)ã«ãããŠååç©çŽïŒã¢ã«ã«å¯Ÿããã©
ã³1.6ä¹è³1.9ã¢ã«ã®å²åã§ãã©ã³ã䜿çšããïŒ (6) å·¥çš(a)ã«ãããŠååç©çŽïŒã¢ã«ã«å¯Ÿããã©
ã³1.75ã¢ã«ã®å²åã§ãã©ã³ã䜿çšããïŒ (7) å·¥çš(a)ãçŽ50ä¹è³115âã®æž©åºŠã«å ç±ããŠè¡
ãªãïŒ (8) å·¥çš(a)ãéæµãã«ãšã³äžã§è¡ãªãïŒ (9) å·¥çš(b)ã«ãããŠååç©ã®ç¡ŒçŽ é¯å¡©ãçé žã
ãªã«ãçé žãããçé žããã³ããªçé žããæã
矀ããéžã°ããé žã§åŠçããïŒ (10) å·¥çš(b)ã«ãããŠååç©ã®ç¡ŒçŽ é¯å¡©ãç¡æ°Žç
é žããã³ïŒé žåçã§åŠçããïŒ (11) å·¥çš(b)ã«ãããŠååç©ã®ç¡ŒçŽ é¯å¡©ãå åé
å°ã®ç¡æ°Žçé žãšïŒé žåçã§åŠçããïŒ (12) å·¥çš(b)ã50â100âã®æž©åºŠç¯å²å ã§è¡ãªãïŒ (13) å·¥çš(b)ã70â75âã®æž©åºŠç¯å²å ã§è¡ãªãïŒ (14) å·¥çš(b)ã70â75âã®æž©åºŠç¯å²å ã§ç¡æ°Žçé ž
ããã³ïŒé žåçã䜿ã€ãŠè¡ãªãã ä»ã®å¥œãŸããæ æ§ã¯ (a) åŒïŒ ïŒåŒäžïŒ²ã¯ã·ã¯ãããã«åã¯ã·ã¯ããããã«
ãããŸãR2ã¯äœçŽã¢ã«ãã«ãããããè¡šããïŒ
ã§ç€ºãããååç©ãäžæŽ»æ§ææ©æº¶åªäžãã©ã³å
ã¯ãã©ã³çºçæºã§éå ããŠåŒïŒ ïŒåŒäžïŒ²ãšR2ã¯äžã«å®çŸ©ãããšãããšããïŒ
ããã€ååç©ã®ç¡ŒçŽ é¯å¡©ãçæãïŒ (b) ååç©ã®ç¡ŒçŽ é¯å¡©ãæ°Žæ§é žã§å æ°Žå解ããŠ
ååç©ãçæãïŒ (c) ååç©ãçé žããªã«ãçé žãããçé žãã
ã³ããªçé žããæã矀ããéžã°ããé žã§ç°åã
æ¬è³ªçã«å®äºããè¿åŠçããŠåŒLVïŒ ïŒåŒäžïŒ²ãšR2ã¯äžã«å®çŸ©ãããšãããšããïŒ
ã§ç€ºãããååç©ãçæãããã€å¿ èŠãªãã° (d) ååç©LVã®R2OâãšãŒãã«å®èœåºã
NaSC2H5ãèåæ°ŽçŽ é žãïŒèåç¡ŒçŽ åã¯ããª
ãžã³å¡©é žå¡©ã§è£éããŠåŒLXïŒ ïŒåŒäžïŒ²ã¯äžã«å®çŸ©ãããšãããšããïŒã§ç€º
ãããååç©ãçæããïŒ é£ç¶å·¥çšããæãåŒïŒ¬ïŒ ïŒåŒäžïŒ²ã¯ã·ã¯ãããã«åã¯ã·ã¯ããããã«
ãããŸãR2ã¯æ°ŽçŽ åã¯äœçŽã¢ã«ãã«ãããã
ãè¡šããïŒã§ç€ºãããååç©é¡ã®è£œæ³ã§ããã ãŸãå·¥çš(c)ã¯ååç©ããã©ã³ã§åŠçããåŸ
äžèšã®ãšããé žè§Šåªã§åŠçããåé¢å·¥çšã§è¡ãª
ãããšãåºæ¥ãã åŒïŒ¬ãç¹åŸŽãšããååç©é¡ã®äžèšè£œæ³ã®å¥œãŸã
ãæ æ§ã¯ (1) å·¥çš(c)ã70â90âã®æž©åºŠç¯å²ã§è¡ãªãïŒãã
ã³ (2) å·¥çš(c)ã80â85âã®æž©åºŠç¯å²ã§ç¡æ°Žçé žã䜿
çšããŠè¡ãªãïŒ ããšã§ããã æã奜ãŸããå®æœæ æ§ã¯ (a) åŒVaïŒ ããã€ååç©Vaããã«ãšã³äžã§ååç©VaçŽïŒ
ã¢ã«åœãçŽ1.75ã¢ã«ã®å²åã®ãã©ã³ãšçŽ50ä¹è³
115âã«å ç±ããŠéå ãåŒïœïŒ ããã€ååç©ã®ç¡ŒçŽ é¯å¡©ãçæãïŒ (b) ååç©ïœã®ç¡ŒçŽ é¯å¡©ãå åéå°ã®ç¡æ°Žç
é žïŒïŒé žåç6.4ïŒïŒã®æ··åç©ãšç°åãæ¬è³ªç
ã«å®äºããè¿çŽ70â75âã®æž©åºŠã«å ç±åŠçããŠ
åŒLVaïŒ ããã€ååç©ãçæãïŒãã€å¿ èŠãªãã° (c) ååç©LVaãNaSC2H5ãèåæ°ŽçŽ é žãïŒè
åç¡ŒçŽ åã¯ããªãžã³å¡©é žå¡©ã§è±ã¡ãã«ååå¿ã
è¡ãªã€ãŠåŒLXaïŒ ããã€ååç©ãçæãïŒãŸãå¿ èŠãªãã° (d) ååç©LXaããã®æè¡åéã§ç¥ãããæ¹æ³
ã§ãã®è£œè¬äžèš±å®¹ãããé žä»å å¡©ã«è»¢åããé£
ç¶å·¥çšããæãåŒLâ²ïŒ ïŒåŒäžïŒ²ã¯æ°ŽçŽ åã¯ã¡ãã«ãè¡šããïŒã§ç€ºã
ããååç©ã®è£œæ³ã§ããã ååç©é¡ïŒ®âã·ã¯ããããã«ã¡ãã«â14βâã
ãããªãã·âïŒâã¡ããªãã·âã¢ã«ãã€ãã³ã
âã·ã¯ãããã«ã¡ãã«â14βâããããªãã·âïŒ
âã¡ããªãã·ã¢ã«ãã€ãã³ãâã·ã¯ããããã«
ã¡ãã«âïŒïŒ14βâãžããããªãã·ã¢ã«ãã€ãã³
ããã³ïŒ®âã·ã¯ãããã«ã¡ãã«âïŒïŒ14βâãžã
ãããªãã·ã¢ã«ãã€ãã³ã¯ç¥ãããŠå± ãç±³åœç¹èš±
第3819635å·ã«èšèŒãããŠããã æ¬æ现æžã«ãããŠâäžæŽ»æ§ææ©æº¶åªâãšã¯åå¿
ã«ãã€ãŠå€åããªãæ§ã«åå¿ã«äŸããªãææ©æº¶åª
ãæå³ããããã®æ§ãªæº¶åªã¯å¡©åã¡ãã¬ã³ãã¯ã
ãããªã«ã ããžã¯ãããšã¿ã³ãããã©ã¯ããã¡ã¿
ã³ããã³ãŒã³ããã«ãšã³ããšãŒãã«ãé ¢é žãšã
ã«ããã·ã¬ã³ãããã©ããããã©ã³ãžãªã¯ãµã³ã
ãžã¡ãã«ã¢ã»ãã¢ããçã§ããã æ¬æ现æžäžæž©åºŠã¯ãã¹ãŠææ°ã床ã以ã€ãŠè¡šã
ããVPCã¯èžæ°çžã¯ãããã°ã©ãæ³ãæå³ããã
IRã¯èµ€å€ç·ã¹ãã¯ãã«ãããŸãNMRã¯æ žç£æ°å ±
鳎ã¹ãã¯ãã«ãããããæå³ããã 以äžã«æ¬çºæäžéäœã®è£œé ãçµãŠæçµçšéåå
ç©ã«è³ã補é å®éšäŸã瀺ãã äŸ ïŒ ïŒâã·ã¯ãããã«ã«ã«ããã«âïŒâïŒïœâã¡ã
ãªãã·ãã³ãžã«ïŒâïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒ
ïŒïŒïŒâãªã¯ã¿ãããã€ãœãããªã³ïŒïœïŒ å¡©åã¡ãã¬ã³200mläžã«ïŒâïŒïœâã¡ããªãã·
ãã³ãžã«ïŒâïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒâ
ãªã¯ã¿ãããã€ãœãããªã³å¡©é žå¡©ïœïŒ29.4ïœã
0.1ã¢ã«ïŒã溶解ã氷济äžã§å·åŽæ¹æããªããã
ããã«ããªãšãã«ã¢ãã³ïŒ22.2ïœã0.22ã¢ã«ïŒã
å ããããã®æ··åç©ãïŒä¹è³ïŒâã®æž©åºŠã«ä¿ã¡æ¹
æããªããããã«å¡©åã¡ãã¬ã³30mläžã«å¡©åã·ã¯
ãããã«ã«ã«ããã«ïŒ13ïœã0.107ã¢ã«ïŒãå«ã
液ãäžæ»Žã¥ã€å ãããåå¿æ··åç©ã宀枩ã§ïŒæé
æ¹æããåŸæ°Ž100mlãå ãæŽã«10ïŒ ç¡«é ž50mlãå
ããŠé žæ§ãšãå¡©åã¡ãã¬ã³å±€ãåé¢ãããæããª
ãã°ïœãå«ãå¡©åã¡ãã¬ã³æ¶²ãçŽæ¥æ¬¡å·¥çšã«äœ¿
çšããŠãããããããã¯æ¿çž®ããŠæ²¹ãšãæŸçœ®ãã
ã°åºåãããåºäœè©Šæãã¢ã»ãã³ããæ¶åºãããŠ
çµæ¶æ§çæç©ïœãåŸããããèç¹89â61âã äžã®æ¹æ³ã«ãããŠã¢ã·ã«ååå¿ã«ãããã³å容
äœãšããŠæ®é䜿ãããçš®ã ã®ææ©ç¬¬ïŒçŽã¢ãã³é¡
ã¯ããªãšãã«ã¢ãã³ã®ä»£ãã«äœ¿çšåºæ¥ãããã®æ§
ãªã¢ãã³é¡ã«ã¯ããªïŒäœçŽïŒã¢ã«ãã«ã¢ãã³é¡ã
äŸãã°ããªã¡ãã«ã¢ãã³ãããªãšãã«ã¢ãã³çã
ããªãžã³ããžã¡ãã«ã¢ããªã³ãâã¡ãã«ãããª
ãžã³çãããã äŸ ïŒ ïŒâã·ã¯ãããã«ã«ã«ããã«âïŒïŒ10âãšãã
ã·âïŒâïŒïœâã¡ããªãã·ãã³ãžã«ïŒãã«ãã
ãã€ãœãããªã³é¡ïŒïœãšïœïŒ æ³âéé ¢é žé žåæ³ å¡©åã¡ãã¬ã³230mläžã«ïŒâã·ã¯ãããã«ã«ã«
ããã«âïŒâïŒïœâã¡ããªãã·ãã³ãžã«ïŒâïŒïŒ
ïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒâãªã¯ã¿ãããã€ãœ
ãããªã³ïœïŒ0.1ã¢ã«ïŒã®æº¶æ¶²ã«éé ¢é žïŒ40ïŒ ã
23.8ïœã0.12ã¢ã«ïŒã枩床30â35âãä¿ã€æ§ãªé
床ã§å ãããåºæ¥ã液ã宀枩ã§ïŒæéæ¹æãæ°Ž
200mlãå ããåŸ10ïŒ éäºç¡«é žãããªãŠã 液100ml
ãå ããŠéå°ã®éé ¢é žãå解ãããå¡©åã¡ãã¬ã³
çžãåé¢ãæžå§æ¿çž®ããŠæ²¹ç¶æ®æž£ãåŸããããã
èžæ°çžã¯ãããã°ã©ãæ³åæïŒVPCïŒã«ãã€ãŠ
ããã¹ãåŠãã©ã³ã¹ïœãšã·ã¹ïœç°æ§äœãšããª
ãã·ãã®23ïŒ78ã®å²åã®æ··åç©ããæããã®ã§ã
ã€ããå¿ èŠãªãã°ãã®ãšããªãã·ãïŒçš®ãã¢ã«ã
ãåã¯ã·ãªã«ã«ã©ã ã䜿ã€ãŠã«ã©ã ã¯ãããã°ã©
ãæ³ã«ãã€ãŠåé¢åºæ¥ããïŒæº¶é¢å€ãžãšãã«ãšãŒ
ãã«äœ¿çšïŒã ïœâã¡ããªãã·ãã³ãžã«åºãšãªãã·ã©ã³åºã®ç«
äœé¢ä¿ã«ãããŠå°éãšããªãã·ãïŒïœãèç¹
118ãïŒã¯âãã©ã³ã¹åœ¢æ âããã¡ããŸãäž»ãšããª
ãã·ãïŒïœãèç¹82â84ãïŒã¯âã·ã¹åœ¢æ âã
ãã€ãŠããã æ³âãã«ããªãã«ãªãé ¢é žé žåæ³ å¡©åã¡ãã¬ã³125mläžã«ïŒâã·ã¯ãããã«ã«ã«
ããã«âïŒâïŒïœâã¡ããªãã·ãã³ãžã«ïŒâïŒïŒ
ïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒâãªã¯ã¿ãããã€ãœ
ãããªã³ïœïŒ0.05ã¢ã«ïŒã®æº¶æ¶²ã«çé žãããªãŠ
ã ïŒ20ïœã0.19ã¢ã«ïŒãå ãæ··åç©ã0ãã«å·åŽã
ããå¡©åã¡ãã¬ã³35mläžã«ç¡æ°Žããªãã«ãªãé ¢é ž
ïŒ16.6ïœã0.077ã¢ã«ïŒãš90ïŒ éé žåæ°ŽçŽ ïŒ2.94ïœã
0.077ã¢ã«ïŒãïŒâã§æ··åããŠãã«ããªãã«ãªã
é ¢é žã®æ¶²ãã€ãã€ããïœã®åå¿æ··åç©ã«éé žæ¶²
ãåå¿æž©åºŠãïŒä¹è³5ãã«ä¿ã€æ§ãªé床ã§æ»Žå ã
ããæ·»å çµäºåŸåå¿æ··åç©ãïŒä¹è³ïŒâã§30åé
æ¹æããåŸ10ïŒ éäºç¡«é žãããªãŠã 液ãå ããŠ
CO2ã®çºçãæ¢ãè¿æ¹æããŠéå°ã®éé žãå解ã
ããå¡©åã¡ãã¬ã³çžãæ°ŽæŽãç¡æ°Žç¡«é žãããªãŠã
äžããšãããŠä¹Ÿç¥ãæžå§æ¿çž®ããŠæ²¹ç¶æ®æž£ãåŸ
ããããã¯VPCã«ããã°ãã©ã³ã¹ïŒã·ã¹æ¯35ïŒ
65ã®ïœãšïœç°æ§äœãšããªãã·ãã§ãã€ãã äŸ ïŒ ïŒâã·ã¯ãããã«ã«ã«ããã«âïŒïŒ10âãžãã
ããªãã·âïŒâïŒïœâã¡ããªãã·ãã³ãžã«ïŒã
ã«ãããã€ãœãããªã³ïŒVaãšïœïŒ äŸïŒã®éé ¢é žé žåæ³ããã®ïœãšïœç°æ§äœãš
ããªãã·ãæ··åç©ãã¢ã»ãã³30mlã«æº¶è§£ãïŒâã«
å·åŽããããã®æ¶²ã«å ã¥æ°Ž30mlãå ããåŸæž©åºŠã
25â以äžã«ä¿ã€æ§ãªé床ã§æ¿ç¡«é ž30mlãå ããã
åå¿æ··åç©ã25ãã§1.5æéæ¹æããåŸæ°Ž150mlãš
ãã«ãšã³300mlãå ããããã®ïŒçžæ··åç©ãæ°Žé ž
åãããªãŠã 溶液ã§ã¢ã«ã«ãªæ§ãšããã«ãšã³å±€ã
åé¢ãæ¿çž®ããŠæ²¹ç¶æ®æž£ãåŸãããã®æ²¹ãã·ã¯ã
ãããµã³300mlãšæ¹æãåŸãçœè²åºäœæžæ¿æ¶²ã
éããŠåºäœãæéããããã®çœè²åºäœã¯VPCã«
ãã€ãŠäž»ãšããŠæããã©ã³ã¹ãžãªãŒã«Vaãšå°é
ã®ãã©ã³ã¹ç°æ§äœãžãªãŒã«ïœããæããšããã€
ããæåã®ã¢ãã³ïœããèšç®ããVaåçã¯75
ïŒ ã§ãã€ããã·ã¯ããããµã³æ¶²ã¯ç¡«é žã§åŠçã
ãŠæŽã«ãã©ã³ã¹ãžãªãŒã«ã®10ïŒ åçãåŸããçœè²
åºäœãã¢ã»ããããªã«ããæŽã«æ¶åºç²Ÿè£œããŠèç¹
145â147ãã®ç©è³ªãåŸããäžèšäœ¿çšã®æ¿ç¡«é žã®ä»£
ãã«ç¡é žãå¡©é žãèåæ°ŽçŽ é žã®æ§ãªä»ã®é žé¡åã¯
ã¢ã«ãã«ã¹ã«ããªã³é žãããªãã«ãªãé ¢é žã®æ§ãª
匷ææ©é žé¡ã䜿çšåºæ¥ãã äžèšæ¹æ³ã«ããå°éã®çŽãã©ã³ã¹ãšããªãã·ã
ïœã®å æ°Žå解ã¯æããã©ã³ã¹ãžãªãŒã«Vaã®ã¿
ãåŸããããäž»ã·ã¹ãšããªãã·ãïœã®å æ°Žå解
ã¯æããã©ã³ã¹ãžãªãŒã«Vaãšå ±ã«å°éã®ãã©ã³
ã¹ãžãªãŒã«ç°æ§äœïœãåºæ¥ãããã®VaïŒïœ
æ¯çã¯86ïŒ14ã§ããã äŸ ïŒ ïŒâã·ã¯ãããã«ã¡ãã«âïŒïŒ10âãžããããª
ãã·âïŒâïŒïœâã¡ããªãã·ãã³ãžã«ïŒãã«ã
ããã€ãœãããªã³ïŒïœïŒ ããã©ããããã©ã³300mläžã«ïŒâã·ã¯ããã
ã«ã«ã«ããã«âïŒïŒ10âãžããããªãã·âïŒâ
ïŒïœâã¡ããªãã·ãã³ãžã«ïŒãã«ãããã€ãœãã
ãªã³ïŒ30.0ïœã0.08ã¢ã«ïŒã®æº¶æ¶²ã«çªçŽ é°å²æ°ã®
ããšã§æ³šå°éããšãããŠãã©ã³ãžã¡ãã«ç¡«åç©ç
ïŒãïŒæº¶æ¶²ïŒ14mlã0.14ã¢ã«ïŒãå ãããåŸãæ··
åç©ãïŒæééæµå ç±ããåŸæžå§æ¿çž®ã溶åªãé€
å»ãããåŸãã·ã¯ãããã«ã¡ãã«ã¢ãã³ïœã®ã
ã©ã³é¯ååç©ã¯çŽæ¥æ¬¡åå¿ã«äœ¿çšåºæ¥ããåã¯å¡©
é žã®æ§ãªæ°Žæ§é žã§å æ°Žå解ããŠïœïŒèç¹120â
122âïŒãåŸãããããã©ã³ã¹ãžãªãŒã«Vaã¢ãã
å®èœåºã次ã®ãã©ã³çºçæºã§éå ããŠãïœãåŸ
ãããïŒ ïŒ ãã©ã³âããã©ããããã©ã³é¯ååç©ã ïŒ ç¡Œæ°ŽçŽ åãããªãŠã ãšïŒãµã€åç¡ŒçŽ ã¬ã¹åã¯
ïŒãµã€åç¡ŒçŽ ããã©ããããã©ã³é¯ååç©åã¯
ïŒãµã€åç¡ŒçŽ ã¢ã«ãã«ãšãŒãã¬ãŒãã䜿çšããŠ
ããã©ããããã©ã³äžãã®å Žã§çºçãããã©
ã³ã äŸ ïŒ ïŒ®âã·ã¯ãããã«ã¡ãã«â14βâããããªãã·
âïŒâã¡ããªãã·ã¢ã«ãã€ãã³ïŒLVaïŒ ïŒ¡æ³âŠãã©ã³é¯ååç©ã䜿çšããç°ååå¿ äŸïŒã®ãã©ã³éå åå¿ããåŸããã©ã³é¯ååç©
æ®æž£ã«ç¡æ°Žçé žïŒ85ïŒ çé žãšïŒé žåçããã€ãã€
ãïŒ320ïœãšïŒé žåç50ïœãå ããããã®æ··åç©
ã宀枩ã§30åéæ¹æããåŸ70â75âã§ïŒæéæ¹æ
ãããåå¿æ··åç©ãæ°Ž200mlã§ããããåŸæ¿æ°Žé ž
åã¢ã³ã¢ããŠã 600mlãšç æ°·ïŒã®æ··åç©äžã«æ³š
å ¥ããããã®æ··åç©ãããã¿ã³400mlã§æœåºãã
ãã¿ã³æœåºæ¶²ãç¡«é žãããªãŠã äžããšãããŠä¹Ÿç¥
ããåŸæ¿çž®ããŠæ²¹ç¶çæç©LVa23.1ïœïŒ85ïŒ å
çïŒãåŸãããã®æ²¹ãã¢ã»ãã³ã«ãšããç¡æ°Žå¡©å
æ°ŽçŽ ã¬ã¹ã§åŠçããŠçæç©LVaã®çµæ¶æ§å¡©é žå¡©
ãåŸããèç¹248â250âã æ³âŠã©ããªç¡ŒçŽ é¯å¡©ã䜿çšãã¬ç°åæ¹æ³ ïŒâã·ã¯ãããã«ã¡ãã«âïŒïŒ10âãžããããª
ãã·âïŒâïŒïœâã¡ããªãã·ãã³ãžã«ïŒãã«ãã
ãã€ãœãããªã³a1.5ïœãšç¡æ°Žçé ž16.0ïœã80â
85ãã§23æéæ¹æããããã®åå¿æ··åç©ãæ°Ž20ml
ã§ããããåŸæ°·ãšæ¿æ°Žé žåã¢ã³ã¢ããŠã 35mlã®æ··
åç©äžã«æ³šå ¥ãããæ··åç©ãå¡©åã¡ãã¬ã³40mlã§
æœåºãæœåºæ¶²ãæ¿çž®ããŠæ²¹1.15ïœãåŸããèžæ°çž
ã¯ãããã°ã©ãæ³âåå åææ³ã«ãã€ãŠæ²¹ã¯æã
âã·ã¯ãããã«ã¡ãã«â14βâããããªãã·â
ïŒâã¡ããªãã·ã¢ã«ãã€ãã³LVa57ïŒ ãè±æ°Žã
ããå¯æç©27ïŒ ããã³éç°åïœåæç©è³ª15ïŒ ã
ãæããã®ã§ãã€ãã äŸ ïŒ å·Šææ§ïŒ®âã·ã¯ãããã«ã¡ãã«â14βâããã
ãªãã·âïŒâã¡ããªãã·ã¢ã«ãã€ãã³ïŒLVaâ²ïŒ äŸïŒã®æ¹æ³ã«ãããŠå³ææ§ïŒâïŒïœâã¡ããªã
ã·ãã³ãžã«ïŒâïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒ
âãªã¯ã¿ãããã€ãœãããªã³å¡©é žå¡©ã®ä»£ãã«ã©ã»
ãäœïœãçšã次ãã§äŸïŒãïŒã®æ¹æ³ãé©çšããŠ
å·Šææ§çæç©LVaâ²ãåŸãã äŸïŒãšïŒã®æ¹æ³ã次ã®ãšããè¡ãªã€ãããã«ãš
ã³100mläžã«å·Šææ§ïŒâã·ã¯ãããã«ã«ã«ããã«
âïŒïŒ10âãžããããªãã·âïŒâïŒïœâã¡ããªã
ã·ãã³ãžã«ïŒãã«ãããã€ãœãããªã³ïŒ10ïœã
0.0267ã¢ã«ïŒã®æ¶²ã«çªçŽ é°å²æ°ã®ããšã§æ³šå°éã
ãšãããŠãã©ã³ãžã¡ãã«ç¡«åç©ç溶液ïŒïŒmlã
0.057ã¢ã«ïŒãå ãããåŸã液ãïŒæééæµèžç
ãæžå§æ¿çž®ããŠçŽ40mlã®æº¶åªãé€å»ãå·Šææ§ã·ã¯
ãããã«ã¡ãã«ã¢ãã³aâ²ã®ãã©ã³é¯ååç©ãçŽ
æ¥ç°ååå¿ã«äœ¿ã€ãã å·Šææ§ã·ã¯ãããã«ã¡ãã«ã¢ãã³aâ²ã®ç°åå
å¿ã¯ç¡æ°Žçé ž200ïœãšïŒé žåç35ïœãïŒâ25ãã®æž©
床ã§æ¹æããªããäžèšãã«ãšã³âãã©ã³é¯ååç©
æ··åç©ãå°ãã¥ã€å ããŠè¡ãªã€ããæ·»å å®äºåŸæ··
åç©ã70âã«å ç±ãïŒæéæ¹æããåŸãããæ¿æ°Ž
é žåã¢ã³ã¢ããŠã 400mlãšçŽ25ãã®æž©åºŠã«ä¿ã€ã«å
åã®æ°·ãšã®æ··åç©äžã«æ³šå ¥ããããã®æ··åç©ãã
ã«ãšã³ã§æœåºããã«ãšã³æœåºæ¶²ãæ°ŽæŽããåŸæžå§
æ¿çž®ããŠå·Šææ§ïŒ®âã·ã¯ãããã«ã¡ãã«â14βâ
ããããªãã·âïŒâã¡ããªãã·ã¢ã«ãã€ãã³
ïŒLVaâ²ïŒå¡©åºãåŸãããã®æ²¹ç¶å¡©åºãç¡«é žã§åŠç
ããŠç¡«é žå¡©ã«è»¢åãå·Šææ§ïŒ®âã·ã¯ãããã«ã¡ã
ã«â14βâããããªãã·âïŒâã¡ããªãã·âã¢ã«
ãã€ãã³7.2ïœãåŸããèç¹232â237âïŒå解ïŒ
ãαãdâ55.4âãïŒïœïŒ0.56ãCH3OHïŒã äŸ ïŒ ïŒâã·ã¯ããããã«ã«ã«ããã«âïŒâïŒïœâã¡
ããªãã·ãã³ãžã«ïŒâïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒ
ïŒïŒïŒïŒïŒâãªã¯ã¿ãããã€ãœãããªã³ïŒ
ïœïŒ äŸïŒã®æ¹æ³ã«ãããŠäœ¿çšããå¡©åã·ã¯ãããã«
ã«ã«ããã«ã®ä»£ãã«çã¢ã«éã®å¡©åã·ã¯ãããã
ã«ã«ã«ããã«ã䜿ã€ãŠéŠé¡ç©è³ªïœãçæããã äŸ ïŒ ïŒâã·ã¯ããããã«ã«ã«ããã«âïŒïŒ10âãšã
ãã·âïŒâïŒïœâã¡ããªãã·ãã³ãžã«ïŒãã«ã
ããã€ãœãããªã³é¡ïŒïœããã³ïœïŒ äŸïŒã®æ¹æ³ã«ãããŠäœ¿çšããã©ã»ãäœïœã®ä»£
ãã«çã¢ã«éã®ïœã䜿ã€ãŠéŠé¡ååç©ïœãš
ïœãçæããã äŸ ïŒ ïŒâã·ã¯ããããã«ã«ã«ããã«âïŒïŒ10âãžã
ãããªãã·âïŒâïŒïœâã¡ããªãã·ãã³ãžã«ïŒ
ãã«ãããã€ãœãããªã³ïŒïœïŒïœïŒ äŸïŒã®æ¹æ³ã«ãããŠäœ¿çšããã©ã»ãäœïœãã
ã³ïœã®ä»£ãã«çã¢ã«éã®ïœããã³ïœã䜿ã€
ãŠéŠé¡ååç©ïœãšïœãçæããã äŸ 10 ïŒâã·ã¯ããããã«ã¡ãã«âïŒïŒ10âãžããã
ãªãã·âïŒâïŒïœâã¡ããªãã·ãã³ãžã«ïŒãã«
ãããã€ãœãããªã³ïŒïœïŒ äŸïŒã®æ¹æ³ã«ãããŠäœ¿çšããã©ã»ãäœïœã®ä»£
ãã«çã¢ã«éã®Vbã䜿ã€ãŠéŠé¡ååç©ïœãç
æããã äŸ 11 âã·ã¯ããããã«ã¡ãã«â14βâããããªã
ã·âïŒâã¡ããªãã·ã¢ã«ãã€ãã³ïŒLVbïŒ äŸïŒã®æ¹æ³ã«ãããŠäœ¿çšããã©ã»ãäœïœã®ä»£
ãã«çã¢ã«éã®ïœã䜿ã€ãŠéŠé¡çæç©LVbã
çæããã äŸ 12 âã·ã¯ãããã«ã¡ãã«âïŒïŒ14âãžããããª
ãã·ã¢ã«ãã€ãã³ïŒLXaïŒ 48ïŒ HBr10mläžã«ïŒ®âã·ã¯ãããã«ã¡ãã«â
14βâããããªãã·âïŒâã¡ããªãã·ã¢ã«ãã€ã
ã³ïŒLVaïŒïŒ1.0ïœã2.58ããªã¢ã«ïŒã®æ··åç©ãçª
çŽ é°å²æ°ã®ããšã§ïŒåééæµèžçãããå·åŽåŸå
å¿æ··åç©ãæ°Žã§çšéãæ°Žé žåã¢ã³ã¢ããŠã 氎溶液
ã§ã¢ã«ã«ãªæ§ãšããããã®æ¶²ãã¯ããããªã«ã ã§
æ°åæœåºã䜵ããæœåºæ¶²ãç¡æ°Žç¡«é žãããªãŠã äž
ããšãããŠä¹Ÿç¥ããã溶åªãèžçºããŠåŸãæ²¹730
mgã也ç¥ãšãŒãã«ã«ãšããåŸã液ãããè»åâå
çããšããéããã液ãå¡©åæ°ŽçŽ ã飜åãã
ã也ç¥ãšãŒãã«ã§åŠçãåŸãå¡©é žå¡©ãæéããŠã¡
ã¿ããŒã«âã¢ã»ãã³ããæ¶åºãããŠïŒ®âã·ã¯ãã
ãã«ã¡ãã«âïŒïŒ14âãžããããªãã·ã¢ã«ãã€ã
ã³å¡©é žå¡©LXa565mgïŒ56.5ïŒ ïŒãåŸããèç¹272â
274ãïŒå解ïŒãIRãšNMRã¹ãã¯ãã«ã¯æ§é ãšäžèŽ
ããã C21H29NO2ã»HClã»ïŒïŒïŒCH3OHã«å¯Ÿããåæå€ ïŒ ïŒ èšç®å€ïŒïŒ£ã67.97ïŒïŒšã8.49ïŒïŒ®ã3.49ã 枬å®å€ïŒïŒ£ã68.10ïŒïŒšã8.14ïŒïŒ®ã3.80ã äžèšã®ä¹Ÿç¥ãšãŒãã«æ¶²ãé©åœããé žé¡ã§é žæ§
ãšããŠLXaã®çš®ã ã®â補è¬äžèš±å®¹ãããé žä»å
å¡©é¡âãåŸãã âã·ã¯ãããã«ã¡ãã«â14βâããããªãã·
âïŒâã¡ããªãã·ã¢ã«ãã€ãã³ã®ïŒâã¡ããªãã·
ãšãŒãã«å®èœåºã¯NaSC2H5ãïŒèåç¡ŒçŽ ãåã¯
ããªãžã³å¡©é žå¡©ã®æ§ãªãšãŒãã«è£éå€ã§åŠçããŠ
è£éãæããžã¡ãã«åããçæç©LXaãåŸãã
ãšãåºæ¥ãã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ åŒïŒ ïŒåŒäžïŒžã¯ã«ã«ããã«ïŒïŒïŒ¯ïŒããã¯ã·ã¯ã
ãããã«åã¯ã·ã¯ãããã«ãããã€R2ã¯äœçŽã¢
ã«ãã«ãããããè¡šããïŒã§ç€ºãããååç©ã®è£œ
é æ³ã§ãã€ãŠã ïŒåŒäžã®ïŒ²ããã³R2ã¯åèšå®çŸ©ã®ãšããã§ã
ãïŒããã€ååç©ãç¡æ©ãŸãã¯ææ©ã®åŒ·é žã§åŠç
ããŠè¡šèšã®ç®çååç©ã補é ããããšãç¹åŸŽãšã
ãæ¹æ³ã ïŒ åŒïŒ ïŒåŒäžïŒžã¯H2ããã¯ã·ã¯ããããã«åã¯ã·
ã¯ãããã«ãããã€R2ã¯äœçŽã¢ã«ãã«ãããã
ãè¡šããïŒã§ç€ºãããååç©ã®è£œé æ³ã§ãã€ãŠã ïŒåŒäžã®ïŒ²ããã³R2ã¯åèšå®çŸ©ã®ãšããã§ã
ãïŒããã€ååç©ãç¡æ©ãŸãã¯ææ©ã®åŒ·é žã§åŠç
ããŠïŒžãã«ã«ããã«ïŒïŒïŒ¯ïŒã§ããè¡šèšã®åŒã®ã«
ã«ããã«ååç©ã補é ãã次ãã§è©²ã«ã«ããã«åº
ãéå ããŠè¡šèšã®ç®çååç©ã補é ããããšãç¹
城ãšããæ¹æ³ã
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/669,795 US4058531A (en) | 1976-03-23 | 1976-03-23 | Process for the preparation of 14-hydroxymorphinan derivatives |
US669795 | 1976-03-23 | ||
US769808 | 1977-02-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS60185765A JPS60185765A (ja) | 1985-09-21 |
JPS649316B2 true JPS649316B2 (ja) | 1989-02-16 |
Family
ID=24687778
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP60016685A Granted JPS60185765A (ja) | 1976-03-23 | 1985-02-01 | ããããã·ã¢ã«ãã£ãã³èªå°äœã®è£œé æ³ |
Country Status (2)
Country | Link |
---|---|
US (2) | US4058531A (ja) |
JP (1) | JPS60185765A (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH065042U (ja) * | 1991-02-08 | 1994-01-21 | 平河ãã¥ãŒããã¯æ ªåŒäŒç€Ÿ | ã·ãŒã«ãé»ç· |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4139534A (en) * | 1977-02-17 | 1979-02-13 | Bristol-Myers Company | Process for the preparation of 14-hydroxymorphinan derivatives |
US4202982A (en) * | 1976-03-23 | 1980-05-13 | Bristol-Myers Company | Process for the preparation of 14-hydroxymorphinan derivatives |
US4613668A (en) * | 1983-12-22 | 1986-09-23 | The United States Of America As Represented By The Department Of Health And Human Services | Short total synthesis or morphinan compounds which uses cyclization of a cycloalkylcarbonyl compound selected from cyclopropylcarbonyl and cyclobutylcarbonyl |
WO2006098855A2 (en) * | 2005-03-10 | 2006-09-21 | Mallinckrodt Inc. | Processes for preparing morphinans and intermediates thereof |
AU2017242268A1 (en) * | 2016-03-29 | 2018-10-25 | Hikal Limited | An improved process for the preparation of butorphanol tartrate |
CN112142668B (zh) * | 2019-06-28 | 2022-06-21 | èå·ç迪äºçç©å»è¯æéå ¬åž | äžç§é ç³é žåžæå¡è¯ºåå ¶äžéŽäœçå¶å€æ¹æ³ |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2723268A (en) * | 1955-11-08 | Process and intermediates for preparing | ||
CA919668A (en) * | 1970-06-20 | 1973-01-23 | Murakami Masuo | Morphinan derivatives |
BE788478A (fr) * | 1971-09-08 | 1973-03-06 | Bristol Myers Co | Procede de preparation de composes analgesiques |
US3919237A (en) * | 1972-07-07 | 1975-11-11 | Hoffmann La Roche | Preparation of isomorphinan derivative |
-
1976
- 1976-03-23 US US05/669,795 patent/US4058531A/en not_active Expired - Lifetime
-
1977
- 1977-09-28 US US05/837,123 patent/US4153603A/en not_active Expired - Lifetime
-
1985
- 1985-02-01 JP JP60016685A patent/JPS60185765A/ja active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH065042U (ja) * | 1991-02-08 | 1994-01-21 | 平河ãã¥ãŒããã¯æ ªåŒäŒç€Ÿ | ã·ãŒã«ãé»ç· |
Also Published As
Publication number | Publication date |
---|---|
US4058531A (en) | 1977-11-15 |
JPS60185765A (ja) | 1985-09-21 |
US4153603A (en) | 1979-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR840002428B1 (ko) | 몚륎íŽëŠ° ì ë첎ì ì ì¡°ë°©ë² | |
JPH05507687A (ja) | ããã¯ãªãžã³èªå°äœ | |
JPS6051174A (ja) | æ°èŠã¢ãªâã«ãããªãžã³èªå°äœã®è£œé æ¹æ³ | |
LU86435A1 (fr) | Nouveaux derives du morphinane et de la morphine,leur preparation,leur application comme medicaments et les compositions pharmaceutiques les contenant | |
Manske | An Attempted Synthesis of a Tricyclic System Present in Morphine | |
US4100166A (en) | Novel cis N-cyclopropylmethyl decahydroisoquinoline | |
JPS649316B2 (ja) | ||
US4139534A (en) | Process for the preparation of 14-hydroxymorphinan derivatives | |
US7423152B2 (en) | Process for the manufacture of intermediates in camptothecin production | |
EP0064685A1 (de) | Dibenzo(de,g)chinolin-Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel | |
WO2007010412A2 (en) | Syntheses and preparations of narwedine and related novel compounds | |
EP0106486A2 (en) | Improvements in or relating to novel octahydrobenz(f)isoquinolines | |
JPS6139938B2 (ja) | ||
CA1254208A (en) | 3,7-diazabicyclo¬3.3.1|nonanes and preparation thereof | |
JPS58116434A (ja) | 眮æãããããšããã·ã¢ã«ã«ãâã«ã¢ãã³é¡åã³ããšããã·ã¢ã«ã«ãâã«âã·ã¯ãã¢ã«ãã«ã¢ãã³é¡ | |
PL108610B1 (en) | Method of producing cis-4a-phenylo-2-substituted-2,3,4,4a,5,6,7,7a-octahydro-1h-2-pyrindines | |
JPS5919096B2 (ja) | ãã³ãŸã¢ã«ãã£ãã³èªå°äœã®è£œé æ³ | |
JPH0358340B2 (ja) | ||
CA1091675A (en) | 2-cycloalkylmethyl-9,10-dihydroxy-1-(p- methoxybenzyl)perhydroisoquinoline compounds | |
JPS6212221B2 (ja) | ||
DD206986A5 (de) | Verfahren zur herstellung von pharmakologisch wirksamen 4-/2-hydroxy-4-(subst.)phenyl/-naphthalin-2(1h)-onen und -2-olen | |
CA1192189A (en) | E-homo-eburnane derivatives and a process for preparing same | |
Menard et al. | Ring C substituted 14-hydroxymorphinans and isomorphinans as narcotic antagonists | |
JPS6218552B2 (ja) | ||
JP2651658B2 (ja) | ïŒïŒïŒïŒïŒïŒïŒâããã©ãããã€ã³ããªãžã³èªå°äœ |